Pals1 functions as a tumor suppressor regulating cell polarity, Hippo signaling and cancer progression by Panichkina, Olga
  
Pals1 functions as a tumor suppressor 
regulating cell polarity, Hippo signaling and 
cancer progression  
 
 
 
 
  
 
 
 
 
 
DISSERTATION ZUR ERLANGUNG DES 
DOKTORGRADES DER NATURWISSENSCHAFTEN  
(DR. RER. NAT.) DER FAKULTÄT FÜR BIOLOGIE UND 
VORKLINISCHE MEDIZIN DER UNIVERSITÄT 
REGENSBURG 
 
 
 
 
vorgelegt von 
 
Panichkina Olga 
 
aus 
 
 Kiew, Ukraine 
 
im Jahr 
 
2017 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Das Promotionsgesuch wurde eingereicht am: 
 
 
Die Arbeit wurde angeleitet von: 
Prof. Dr. Dr. Michael Krahn 
 
Unterschrift: 
Table of contents 
 
 
Table of contents 
I. Abbreviations ........................................................................................ 1 
II. Introduction ......................................................................................... 6 
2.1 Epithelial tissue and cell polarity ....................................................................... 6 
2.1.1 The Par complex .............................................................................................................9 
2.1.2 The Crb complex .......................................................................................................... 11 
2.1.3 The Scribble complex .................................................................................................. 13 
2.2 Disruption of cell polarity, epithelial-to-mesenchymal transition and cancer ... 14 
2.3 Hippo signaling pathway and its link to cell polarity ........................................ 19 
III. Aim of the study ................................................................................ 23 
IV. Materials and Methods ..................................................................... 24 
4.1 Equipment ...................................................................................................... 24 
4.2 Materials ........................................................................................................ 25 
4.2.1 Consumables ............................................................................................................... 25 
4.2.2 Chemicals .................................................................................................................... 27 
4.2.3 Antibodies ................................................................................................................... 29 
4.2.4 Enzymes ....................................................................................................................... 30 
4.2.5 Oligonucleotides.......................................................................................................... 31 
4.2.6 Primers for quantitative RT–PCR ................................................................................. 33 
4.2.7 Sequencing primers and cloning vectors .................................................................... 35 
4.2.8 Kits ............................................................................................................................... 36 
4.2.9 Cell culture media and additives ................................................................................. 37 
4.2.10 Solutions and reagents .............................................................................................. 37 
4.2.11 Data bases and software ........................................................................................... 42 
IV.III Methods ....................................................................................................... 43 
4.3 Cloning ........................................................................................................... 43 
4.3.1 Oligonucleotide hybridization for shRNA (gRNA) ....................................................... 43 
4.3.2 Polymerase chain reaction (PCR) ................................................................................ 44 
4.3.3 Vector preparation ...................................................................................................... 45 
  Table of contents 
 
 
 
4.3.4 Plasmid digestion .................................................................................................... 45 
4.3.5 Agarose gel electrophoresis .................................................................................... 45 
4.3.6 Purification of vector/PCR product ......................................................................... 46 
4.3.7 Vector dephosphorylation/PCR product digestion ................................................. 47 
4.3.8 Ligation ........................................................................................................................ 47 
4.3.9 CRISPR/Cas9 cloning .................................................................................................... 48 
4.3.10 Transformation of chemically competent E. coli cells – DH5 alpha .......................... 49 
4.3.11 DNA-preparation ....................................................................................................... 49 
4.3.12 Mini-preparation ................................................................................................... 50 
4.3.13 Restriction digestion ............................................................................................. 50 
4.3.14 Midi-preparation and sequencing ........................................................................ 52 
4.4 Cell culture...................................................................................................... 52 
4.4.1 Cell line propagation ................................................................................................... 52 
4.4.2 Transfection ................................................................................................................ 55 
4.4.3 Conventional liposome/lipid-mediated transfection ............................................. 56 
4.4.4 Lentivirus-mediated gene delivery (transduction) ................................................. 56 
4. 5 Cell proliferation and invasion assays ............................................................. 58 
4.5.1 MTT cell proliferation assay ........................................................................................ 58 
4.5.2 Transwell cell migration assay..................................................................................... 59 
4.5.3 Scratch/wound healing assay ...................................................................................... 60 
4.5.4 Soft Agar Colony Formation Assay .............................................................................. 60 
4.6 Western Blot .................................................................................................................. 61 
4.6.1 Western Blot and SDS-PAGE sample preparation .................................................. 61 
4.6.2 Western Blot ........................................................................................................... 64 
4.7 Immunofluorescence ..................................................................................................... 65 
4.8 Real-time PCR ................................................................................................................. 66 
4.8.1 RNA-isolation .......................................................................................................... 66 
4.8.2 Reverse transcription .............................................................................................. 67 
4.8.3 Real-time PCR.......................................................................................................... 68 
4.9 Animal treatment and xenotransplantation .................................................................. 70 
4.10 Statistical analysis......................................................................................................... 71 
V. Results ............................................................................................... 72 
5.1 Pals1 knockdown affects TJ formation ............................................................. 72 
  Table of contents 
 
 
 
5.2 Loss of Pals1 results in altered expression of polarity proteins ......................... 76 
5.3 Lack of Pals1 expression leads to enhanced cell motility .................................. 78 
5.4 Pals1 downregulation leads to overexpression of EMT markers and affects 
Hippo signaling pathway ....................................................................................... 79 
5.5 Pals1 knockdown affects cell polarity in HCT116 colon cancer cell line ............. 82 
5.6 Pals1-deficient cells show augmented cell proliferation ................................... 87 
5.7 Lack of Pals1 expression leads to enhanced cell motility in epithelial and colon 
cancer cell lines .................................................................................................... 89 
5.8 Deregulation of Pals1 expression leads to cellular transformation and 
augmented tumorigenicity .................................................................................... 91 
5.9 Pals1 knockout in HCT116 cell line enhances cell motility and metastases 
formation in mice ................................................................................................. 93 
5.10 TGF-β pathway is implicated in Pals1-dependend cell motility ....................... 95 
VI. Discussion ......................................................................................... 97 
VII. Conclusion and Outlook ................................................................. 105 
VIII. Supplements ................................................................................. 106 
8.1. List of figures ............................................................................................... 106 
8.2. List of tables ................................................................................................ 106 
IX. References ...................................................................................... 109 
 
  Acknowledgments 
 
   
Acknowledgments 
First and foremost, I would like to thank Prof. Dr. Dr. Michael Krahn for 
giving me the opportunity to do my Ph.D. within his research group. Thank you 
for continuous support and for being my first referee.  
I owe my deepest gratitude to PD Dr. Anja K. Wege, who provided me an 
opportunity to join their team and who was supporting me during all animal 
studies. Without this collaboration, it would not be possible to conduct this 
research. 
I would like to thank Prof. Dr. Klein and Prof. Dr. Sprenger for being my 
Ph.D. mentors, for your support, patience and the intense discussions which 
gave me exciting insights into the project. Thank you for your encouragement 
and the extra time spent. Besides my advisors and mentors, I would like to thank 
the rest of my thesis committee: Prof. Dr. Witzgall and Prof. Dr. Längst. 
A heartfelt thank you to all my colleagues from the Institute of Molecular 
and Cellular Anatomy at the University of Regensburg, for your great support, 
especially V.Menath, C. Maassen, L.Osten and O.Maier. Sincere thanks to all 
the members of Pathology Department at Uniklinik Regensburg, especially to 
Rudolf Jung, for helping with IHC studies. Many thanks to all the Ph.D. students 
within the research group not only for providing direct back-up and advice but 
also for a very friendly atmosphere. In particular, I would like to acknowledge S. 
Feicht, R. Sun, B. Schwertner, L.Kullman for their friendship, excellent insights 
into the work and for sharing their comprehensive knowledge. I would also like to 
thank you to all undergraduate students I was supervising during my Ph.D., for 
your hard work and for fun activities we’ve done together. 
I wish to express my sincere thanks to Dr. O. Stelmashenko and to R.Sun 
for comments and criticisms from reading various drafts and parts of my thesis.  
Dear Alex, mom, dad and all my family members, thank you for the 
opportunity to complete my Ph.D., your unceasing encouragement and support. 
Thank you to all my friends I got to know during my Ph.D., for helping me focus 
on the research while having a great time! Thank you to every mentioned person 
as well as anyone I might have forgotten.  
Abstract 
 
   
Abstract 
 Epithelial cell polarity is of vital importance for the organization and 
function of epithelial tissues and is primarily maintained by three protein 
complexes, the Crumbs complex, the Par complex and the Scribble complex. 
Most of the polarity proteins within these complexes are highly conserved and 
play pivotal roles in embryonic development, cell-cell adhesion and cell 
migration. Recent studies have demonstrated that deregulation of epithelial 
polarity is a hallmark of tumor progression, in particular during the metastatic 
process. This study was conducted to examine the role of the tight junction 
protein Pals1 in the maintenance of cell polarity, and cancer. RNA interference 
and CRISPR/Cas9 gene deletion approaches were used to downregulate or 
deplete Pals1 in MDCKII, HCT116 and DLD1 cell lines. Reduction in Pals1 
resulted in atypical expression levels of polarity proteins and defects in Hippo 
pathway regulation. Moreover, Pals1 loss caused E-cadherin reduction and 
enhanced cell migration. Pals1 deficient cells exhibited typical markers, inferring 
epithelial-to-mesenchymal transition. Further in vivo xenograft experiments 
revealed a function of Pals1 in cancer progression, as tumors derived from 
Pals1-deficient cells showed increased growth and more extensive liver and lung 
metastases. Taken together, these findings support a close link between 
epithelial cell polarity and tumorigenesis, and suggest the existence of a novel 
Pals1-mediated mechanism of tumor suppression. Thus, the pathophysiological 
consequences of Pals1 alteration must be investigated further, and used to 
develop new therapeutic strategies against this devastating disease. 
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I. Abbreviations 
Abbreviation Name 
AJ Adherens junctions 
AJC Apical junctional complex 
AMOT Angiomotin 
ANOVA Analysis of variances 
AP Alkaline phosphatase 
APC Adenomatous polyposis coli  
aPKC Atypical protein kinase C 
APS Ammonium persulfate 
ATP Adenosine triphosphate 
Birc2 Baculoviral inhibitors of apoptosis repeat-containing 2 
BSA Bovine serum albumin 
C.elegans Caenorhabditis elegans 
Cas9 CRISPR-associated protein 9 
Cdc42 Cell division control protein 42 
Crb Crumbs 
CRIB Cdc42/Rac interactive binding 
CRISPR Clustered regularly interspaced short palindromic repeats 
CTGF Connective tissue growth factor 
Cyr61 Cysteine-rich angiogenic inducer 61 
DAPI 4',6-diamidino-2-phenylindole 
ddH2O Double distilled water 
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DLD1 Colorectal adenocarcinoma cell line, isolated by D.L.Dexter  
DLG Disks large 
DMEM Dulbecco’s Modified of Eagle’s Medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleotide triphosphate 
DTT Dithiothreitol 
E.coli Escherichia coli 
ECM Extracellular matrix 
EDTA Ethylenediaminetetraacetic acid 
EMT Epithelial-to-mesenchymal transition 
EtBr Ethidium bromide 
FCS Fetal calf serum 
FERM 4.1, Ezrin, Radixin, Moesin 
gRNA Guide RNA 
GSK Glycogen synthase kinase  
GTP Guanosine-5'-triphosphate 
Guk Guanylate kinase 
HCT116 Human colon carcinoma tissue 116 
HEK Human embryonic kidney cell line 
HRP Horseradish peroxidase 
IF Immunofluorescence 
IHC Immunohistochemistry 
IKK Inhibitors of κB kinase 
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kb Kilobases  
KD Knockdown 
kDa Kilodalton, 1000 unified atomic mass units 
KO Knockout 
LATS Large tumor suppressor 
LB Lysogeny broth 
LD Loading dye 
Lgl Lethal giant larvae  
LSM Laser scanning microscope 
MAPK  Mitogen-activated protein kinase 
MDCK Madin-Darby Canine Kidney Epithelial Cells 
MET Mesenchymal-to-epithelial transition 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells    
NSG Nod Scid gamma 
OD Optical density 
PAGE Polyacrylamide gel electrophoresis 
Pai1 Plasminogen activator inhibitor 1 
Pals1 Protein associated with Lin seven 1 
par Partitioning defective 
Patj Pals1-associated tight junction protein 
PBS Phosphate buffered saline 
PBTw Phosphate buffered saline with tween 
PDZ Postsynaptic density protein 95, Dlg, ZO-1 
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PEI Polyethyleneimine 
PFA Paraformaldehyde 
PMSF Phenylmethylsulfonylfluoride 
PNK Polynucleotide kinase 
PTEN Phosphatase and tensin homolog deleted on chromosome 10 
puro Puromycine 
RNA Ribonucleic acid 
rpm Revolutions per minute 
RPMI Roswell Park Memorial Institute medium 
SAV1 Salvador family WW domain-containing protein 1 
Scrbld Scrambled 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
SEM Standard error of the mean 
SH3 Src Homolgy3 
shRNA Short hairpin RNA 
SMA Smooth muscle actin 
Smad Sma and Mad related proteins 
TAO Thousand-and-one amino acid protein kinases 
TAZ Transcriptional coactivator with PDZ-binding motif 
TBS Tris-buffered saline 
TEAD TEA domain 
TEMED Tetramethylethylenediamine 
TGF Transforming growth factor 
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TIAM1 T-cell lymphoma invasion and metastasis 1 
TJ Tight junctions 
TNF Tumor necrosis factor 
TRAF TNF receptor-associated factor 
V Volt 
WB Western Blot 
wt Wild type 
YAP Yes-associated protein 
YTA Yeast extract tryptone agar 
ZEB1 Zinc finger E-box-binding homeobox 1 
ZO Zonula occludens 
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II. Introduction 
2.1 Epithelial tissue and cell polarity 
 Mammalian anatomy and physiology are one of the most sophisticated 
areas of biology and medicine. Remarkably, in humans, there are only four 
tissue types identified: epithelial, connective, muscular, and nervous tissues. Cell 
similarity and their related function give tissue identity, although different types of 
tissues can be found in distinct organs (Mescher, Junqueira 2010). Additionally, 
each basic tissue has a unique extracellular matrix (ECM) - a highly dynamic 
structure, consisting of components as water, proteins and polysaccharides. 
ECM continuously undergoes structural remodeling, provides a crucial scaffold 
for all the cellular constituents and participates in cell-cell interactions, tissue 
homeostasis, morphogenesis and biochemical signaling (Frantz et al. 2010).
 Whereas nervous tissue is composed of "finger-like" long cells as axons 
and dendrites, epithelial tissue is mostly made up of polyhedral cells. They form 
different layers with strong cell-cell contacts, and line most internal body cavities. 
Depending on the number of layers and cell shape in the upper layers, epithelial 
tissues are divided into several types. Simple epithelium is presented by one 
layer of cells, while stratified epithelia are considered to have more than two cell 
lining layers. Pseudostratified epithelium belongs to the simple epithelia, as the 
cell nuclei are lying at different levels and only giving an appearance of 
stratification. Further separation of epithelia into subcategories is based on 
differences in cell shape: flat, cubic or elongated morphology, which dictates the 
wide variety of epithelia functions. As the epithelial tissue forms boundaries 
between environments, its main function is a physical and semipermeable 
barrier, regulating absorption and secretion of substances such as water, 
nutrients and ions (Betts 2013; Mescher, Junqueira 2010).   
 All cells in epithelial tissues exhibit some differences in shape and 
structure due to differences in their function, with two types of cell polarization: 
apicobasal polarity and planar cell polarity. This refers to morphological and 
functional asymmetry within an epithelial cell or in the plane of tissue and is 
relevant in a wide range of cellular functions and processes.  Planar cell polarity 
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coordinates cell distribution and behavior across the tissue plane, correlates to 
collective cell movements during body axes elongation, embryonic development, 
hair and bristle growth in Drosophila and mammals. A continuously changing 
environment and polarity information from neighboring cells requires stringent 
coordination and dynamic changes including cell rearrangement, cell division 
and cell-shape changes (Devenport 2014; Zallen 2007). Apico-basal cell polarity 
is established by two different cell-cell junctions - tight junctions (TJ) and 
adherens junctions (AJ), dividing the cell into two biochemically and structurally 
distinct domains. Whereas an apical membrane faces the outside surface of the 
body or the lumen of internal cavities, the basolateral membrane is oriented 
towards the basal lamina and adjacent cells (Khursheed, Bashyam 2014).  
 Despite differences in the distribution of cell-cell junctions, many studies in 
Drosophila, C.elegans and mammals illustrate evolutionary conservation of core 
mechanisms determining cell polarity (Gibson, Perrimon 2003). Three major 
polarity complexes have been identified to date and they serve as the core 
proteins maintaining apicobasal identity in epithelial cells. First, the Crumbs (Crb) 
complex, consisting of the transmembrane protein Crb, the adaptor protein 
associated with Lin seven 1 (Pals1) and Pals1-associated tight junction protein 
(Patj). Together with the partitioning defective (Par) - atypical protein kinase C 
(aPKC) complex, with the adaptor proteins Par3 and Par6 they activate the 
kinase aPKC. Crb and Par-aPKC complexes are required to establish the apical 
plasma membrane. In contrast,  the Scribble homolog (Scrib)–Lethal giant larvae 
homolog (Lgl)–Discs-large homolog (Dlg) complex defines the basolateral 
plasma domain (Martin-Belmonte, Perez-Moreno 2012). 
 Par-aPKC complex serves as a core complex maintaining cell polarity and 
together with Crb complex it is implicated in TJ formation. TJ help to keep 
epithelial cell polarity by forming a paracellular diffusion barrier between the 
apical and basolateral cell domains and hence prevent the movement of solutes 
and lipids across the cell layer (Zihni et al. 2014; Hurd et al. 2003).  To date, TJ 
represent the greatest number of known transmembrane (occludin and claudin 
families) and adaptor zonula occludens (ZO) proteins (ZO-1, ZO-2 and ZO-3) as 
well as signaling proteins, including protein kinases, phosphatases, guanosine-
5'-triphosphate (GTP)-binding proteins, transcriptional and post-transcriptional 
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regulators. Together with more basally formed adherens junctions and 
desmosomes, they establish the apical junctional complex (AJC) and maintain 
polarity and cell-cell adhesion. Figure 2.1 is a simplified representation of the 
organization of epithelial tissue. 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Epithelial cell-cell contacts and adhesion 
Organization and maintenance of cell-cell adhesion in epithelial tissues. (Retrieved and adapted 
from comprehensive system for life science education, University of Tokyo, http://csls-text3.c.u-
tokyo.ac.jp). 
 
 The AJ regulate epithelial paracellular permeability and are linked to the 
actin and microtubule cytoskeletons. The main transmembrane protein of AJ in 
epithelial cells is E-cadherin. It belongs to the family of Ca2+-dependent 
glycoproteins and promotes tight cell-cell contacts by homophilic interaction with 
the cadherin molecules of the neighboring cells. E-cadherin consists of five 
extracellular cadherin repeat domains, one transmembrane domain and a highly 
conserved intracellular tail. Several phosphorylation sites in the intracellular 
domain promote binding affinity to p120-catenin (Reynolds, Roczniak-Ferguson 
2004) and β-catenin (Mehta et al. 2015), further interaction with α-catenin and 
thus actin cytoskeleton.  
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2.1.1 The Par complex 
 The par-titioning-defective or Par proteins were first described in 
Caenorhabditis elegans and afterwards were found in almost all living 
organisms, all the way up to mammals. Interestingly, not only the components of 
Par complex are conserved - they also show a remarkable conservation of their 
localization in epithelial cells from worms to flies and humans. Par proteins 
comprise a complex cell polarity network and are involved in development, 
asymmetric cell division, spatial restriction of the cytoskeleton, formation of cells’ 
polarity axes as well as asymmetric cell division (Aranda et al. 2008). Two 
proteins of the Par family, Par3 and Par6, together with aPKC and small GTPase 
cell division control protein 42 (Cdc42) assemble in the so-called Par complex. 
Par6 serves as a cornerstone protein and is likely to promote an interplay and 
coordination of all polarity complexes (Pieczynski, Margolis 2011a). There are 
three different Par6 isoforms, identified to date in mammals: Par6α, Par6β and 
Par6γ. They are all around 40 kDa in size and share structural organization; 
however, they have different patterns of tissue and subcellular localization. Par6 
is a scaffolding protein and contains a single postsynaptic-density protein 95-Dlg-
ZO-1 (PDZ) domain, responsible for protein-protein interactions usually with 
other PDZ domains or with specific carboxy-terminal motifs, and contributes to 
direct interaction with Par3.  Adjacent to PDZ, the CRIB (Cdc42/Rac interactive 
binding) domain binds the Rho GTPase Cdc42 in a GTP-dependent manner, 
causing conformational changes in Par6 and increasing the affinity of the Par6 
PDZ for its carboxy-terminal ligand by ∼13-fold (Peterson et al. 2004).   
 Two Par3 genes have been identified so far in mammals – Par3A and 
Par3B. Par3A encodes three protein isoforms (180 kDa, 150 kDa, 100 kDa), 
whereas Par3B encodes only one around 140 kDa. Par3A and Par3B are both 
shown to localize apically to TJ at cell-cell contact regions in mammalian cells. 
All three Par3A proteins are characterized by three PDZ domains and a C-
terminal region that interacts with the kinase domain of aPKC. Par3B is not fully 
described to date, however, in contrast to Par3A, it does not seem to bind to 
aPKC. Par3A is broadly expressed in various tissues and can dimerize through 
its N-terminal tail. In the early stages of polarization and junction development, 
Par3A is recruited to the junctional adhesion molecule, thus further serving as an 
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anchor. It also initiates Par6 and aPKC transition to TJ at later developmental 
stages (Assemat et al. 2008). The functionality of Par3 is highly dependent on its 
phosphorylation state, regulated by aPKC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Protein complexes maintaining cell polarity 
Although many proteins participate in apicobasal polarity, three major polarity complexes serve 
as the core proteins maintaining apicobasal cell polarity. These complexes are the apical Crb 
(includes Crb, Pals1 and Patj proteins), Par (includes Par6, Par3 and aPKC proteins) and the 
basolateral Scribble (includes Scribble, Dlg and Lgl proteins) complexes. All of these proteins are 
in a tight interrelation with each other and are highly conserved through evolution (Pieczynski, 
Margolis 2011b). 
  
 Par3 also shows Par6/aPKC-independent activity, as Par3 can interact 
with some of the adhesion molecules through its PDZ domain, including p75 and 
nectin. Furthermore, Par3 together with lipid phosphatase and tensin homolog 
Crb Pals1
1 
Patj 
Par6 
Par3 aPKC
ar3 
Lgl 
Dlg 
Scribble 
Crumbs Complex “Apical” 
Par Complex “Mobile” 
Scribble Complex “Lateral” 
Direct 
Phosphorylation 
Genetic 
Interactions 
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deleted on chromosome 10 (PTEN) might participate in phosphatidylinositide 3 
kinase (PI3K)-Akt-mTOR signaling (Chen, Zhang 2013).  
 Two different aPKC isoforms (aPKCλ/ι and aPKCζ) both play a pivotal role 
in Par complex function. They share a similarity in their unique protein structure, 
having a PB1 domain in the N-terminal, which is required for aPKC-Par6 
interaction. The C-terminal catalytic domain is known to promote phosphorylation 
of Par3 by aPKC (Plant et al. 2003; Chen, Zhang 2013). aPKC-depended 
phosphorylation of other polarity regulators outside the Par complex, like Crb3 or 
Lgl proteins, provides the cross talk among all polarity determinants and is 
crucial in apical domain establishment (Aranda et al. 2008). Figure 2.2 
represents the interaction and signaling redundancy of all polarity complexes. 
 Apart from controlling different aspects of cell polarity, Par proteins are 
also implicated in migratory processes (Crespo et al. 2014), asymmetric cell 
division (Betschinger et al. 2003) and microtubule organization, particularly in the 
positioning and orientation of centrosomes and spindle formation. In neurons, 
Par6-aPKC was shown to co-localize together with dynein to the centrosome and 
thus might play a role in dynein-based transport and glial-guided migration 
(Solecki et al. 2004). In addition, Par complex coordinates actomyosin fiber 
activity, thus is involved in polarized cell migration (Aranda et al. 2008).  
 Despite recent progress in the field, the biochemical relationship and 
crosstalk between Par6, Par3, aPKC and Cdc42 is still not fully understood and 
the functional redundancy of different isoforms makes this network even more 
complicated.   
2.1.2 The Crb complex 
 The Crb complex is highly conserved in both invertebrates and 
vertebrates, consisting of four scaffolding proteins (Crb, Pals1, Patj and Lin-7) 
with numerous protein-protein interaction domains. Decades of research have 
showed Crb to be the key regulator of epithelial integrity. Fly embryos lacking 
Crb  were characterized by disruption of apicobasal polarity and zonula 
adherence defects (Tepass, Knust 1993), whereas the overexpression of Crb 
leads to an enormous expansion of the apical domain with simultaneous 
contraction of the basolateral plasma domain (Wodarz et al. 1995). Crb is a 
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transmembrane protein with a highly conserved intracellular part, containing 
PDZ- and 4.1/ezrin/radixin/moesin (FERM) binding domains (Figure 2.3). In flies, 
through its PDZ-binding motif, the Crb protein can recruit other members of the 
Crb complex, like Stardust (Pals1 homolog in Drosophila), Par6 and aPKC to the 
plasma membrane. The FERM domain is required to recruit Expanded protein to 
the apical membrane, linking Crb complex to Hippo pathway (Pocha, Knust 
2013). In mammals, Crb is encoded by three Crb genes (Crb1, Crb2 and Crb3). 
Crb1 and Crb2 are found to be highly expressed in human retina and brain. Crb3 
is the primary form of Crb and is highly expressed in mammalian epithelial 
tissues (Slavotinek 2016). Crb3 maintains cell polarity and is crucial for correct 
positioning of the Crb complex at the apical membrane (Makarova et al. 2003). 
 
 
Figure 2.3: Structure of the Crb complex in Drosophila (Bulgakova, Knust 2009) 
Proposed model, depicting the structure and organization of Drosophila Crb complex, 
comprising of Crb, Sdt (Pals1 homolog in flies), PATJ and Lin-7 proteins. 
 Pals1 (also known as membrane-associated palmitoylated protein 5 
(MPP5) is a member of a guanylate kinase family protein consisting of two Lin-2 
and Lin-7 (L27) domains (L27N and L27C), a PDZ domain, an SH3 (Src 
Homolgy3) domain, and a Guk (Guanylate kinase) domain. The PDZ domain of 
Pals1 binds Crb3, meanwhile Pals1 via its L27 domain interacts with Pals1-
associated tight junction protein Patj - another member of Crb complex. Hence, 
Pals1 serves as a membrane-associated protein scaffold, linking and mediating 
the indirect interaction of Crb3 and Patj. For instance, Perrimon et al. identified a 
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mechanism in vertebrates by which Crb might act through Pals1 to recruit the 
Par3-Baz complex to the apical cell domain (Hurd et al. 2003). Furthermore, 
mammalian Pals1 is shown to maintain the delivery of E-cadherin to the cell 
surface and is not only sufficient for tight junction development but also is shown 
to be necessary for adherens junction maintenance (Wang et al. 2007). 
Interestingly, Pals1 was also shown to be expressed in T lymphocytes and plays 
a role in nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) 
signaling (Carvalho et al. 2011a). 
 In contrast to Drosophila (Figure 2.3), mammalian Patj contains ten PDZ 
domains and localizes to TJ. According to Shin et al., MDCK cells lacking Patj 
had delayed tight junction formation and cell polarization defects, suggesting that 
Patj plays and important role in Crb complex assembly (Shin et al. 2005). 
Moreover, Patj has been demonstrated to regulate Pals1 accumulation at TJ, 
and Crb3 localization and trafficking (Michel et al. 2005). Furthermore, Patj 
regulates the positioning of aPKC and Par3 to the leading edge during directional 
cell migration (Shin et al. 2007). In flies, Patj regulates AJ stability, by direct 
binding to the myosin-binding subunit, subsequent dephosphorylation and 
inactivation of myosin (Sen et al. 2012). In addition, Patj has a wide range of 
interaction partners, including claudin-1, ZO-1 (Knust, Bossinger 2002), ZO-3 
(Roh et al. 2002a), junctional adhesion molecule 1, nectins (Adachi et al. 2009) 
and angiomotin (AMOT) proteins (Whiteman et al. 2014). Thus, Patj is 
functionally significant for epithelial polarization and plays a key role in 
establishing the apical plasma domain.  
2.1.3 The Scribble complex 
 The Scribble protein was first identified in flies as a crucial regulator of 
morphogenesis and septate junction formation. In combination with the lethal 
giant larvae Lgl and disc large Dlg proteins, it forms the Scribble complex and 
creates the basolateral determinant of a polarized cell. These three proteins are 
known to be tumor suppressors and show multiple interactions via their PDZ-
domain with polarity determinants in Par and Crb complexes. Scribble is shown 
to regulate epithelial cell adhesion and migration, whereas Lgl is likely more 
involved in cell-cell cross-talk and promotes antagonistic interactions with the 
II. Introduction 
14 
 
aPKC-Par3-Par6 complex. Phosphorylation of Lgl by aPKC depends on its 
binding to Par6 and aPKC and leads to a release of Lgl from the plasma 
membrane, and thus helps to control cell shape formation during development. 
Interestingly, besides Dlg function in junctional development which is necessary 
for its targeting to the cytoskeleton, Dlg takes part in proliferation control. Taken 
together, the antagonistic crosstalk between the basal Scribble and apical Par 
and Crb polarity complexes is critical for the establishment of correct apicobasal 
polarity (Su et al. 2012; Woods et al. 1996; Humbert et al. 2008) 
2.2 Disruption of cell polarity, epithelial-to-mesenchymal 
transition and cancer 
 Epithelial cell polarity is fundamental for tissue organization and allows 
cells to respond appropriately to signals from the surrounding microenvironment. 
Hence, a loss of cell polarity might delay or even abort cell responses to 
inhibitory signals and consequently the cell may evade differentiation, 
senescence or apoptosis. Decades of research have demonstrated that a wide 
number of polarity proteins are either tumor suppressors or proto-oncoproteins. 
For instance, Crb3 may act as a tumor suppressor, as downregulation of Crb3 
promotes disruption of cell-cell junctions and increased metastatic potential. Loss 
of Par3, as well as overexpression of Par6α and Par6β proteins,  was shown to 
cause hyperproliferation and enhanced invasiveness in breast cancer cell lines 
and primary tumor tissues (McCaffrey et al. 2012). In addition, Par6γ acts as a 
tumor-suppressor by repressing Akt pathway (Marques et al. 2016). Another 
member of Par complex, aPKCζ, is crucial in pancreatic and hepatocellular 
tissues, as its overexpression correlates with invasiveness and enhanced cell 
proliferation. In addition, all three members of the Scribble complex are known to 
be tumor suppressors, maintaining cell polarity and inhibiting uncontrolled cell 
proliferation (Martin-Belmonte, Perez-Moreno 2012). 
 Polarity proteins might play a crucial role in the metastatic progression of 
cancer, as they are known to mediate front-rear polarization in epithelial cell 
migration during development and tissue repair. Cdc42 is an important regulator 
of directed cell migration. Cdc42 activation of the Par-aPKC complex is shown to 
be important for actin and microtubule network repolarization along the migration 
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axis during spatial migration process (Etienne-Manneville et al. 2005). In 
addition, Par6 and aPKC promote E3 ubiquitin ligase-mediated degradation of 
RhoA and thus control disorganization of the actin cytoskeleton (Wang et al. 
2003). Meanwhile, Par3 is known to control the leading edge of migration by 
activating Rac exchange factor, TIAM1 (T-cell lymphoma invasion and 
metastasis 1) (Pegtel et al. 2007). In intestinal epithelial cells, TIAM1 suppresses 
tumor growth and invasion by regulating Wnt and Hippo signaling  
(Diamantopoulou et al. 2017). Furthermore, numerous studies have underlined 
the physiological importance of proper E-cadherin regulation not only in cell-cell 
adhesion but predominantly in metastatic progression. E-cadherin deregulation 
and depletion cause cellular dedifferentiation and promotes invasiveness in 
human cancers (Rodriguez et al. 2012; Onder et al. 2008; Schneider et al. 2014; 
Singhai et al. 2011).  
 During metastasis, cancer spreads from its original place through the 
lymph or blood stream to other organs, where it gives rise to secondary tumors 
at the distant site. Epithelial-to-mesenchymal transition (EMT) – 
transdifferentiation of epithelial cells into motile fibroblast-like mesenchymal cells 
has been shown to be decisive for tumor cell dissemination in epithelium-derived 
carcinogenesis. EMT is first and foremost essential in embryonic development, 
as during EMT cell loses junctional and apicobasal polarity, undergoes a change 
in the cytoskeleton and signaling programs which enables plasticity and distinct 
cell development during embryogenesis (Lamouille et al. 2014). Moreover, in 
adults, EMT also plays a crucial role, promoting wound healing and tissue 
regeneration and is constituted to the second type of EMT. EMT type III is 
involved in malignant cancer progression (Kalluri 2009). Once the migratory 
cancer cell in type III EMT anchors at the distant epithelial tissue, it undergoes a 
mesenchymal-to-epithelial transition (MET), the reverse process to EMT, and is 
able to form secondary tumors, characterized by an epithelial phenotype 
(Figure 2.4).  
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Figure 2.4: Epithelial-to-mesenchymal transition and reverse process of mesenchymal-
to-epithelial transition  (Kolbl et al. 2016) 
EMT is a process by which the cell loses its epithelial phenotype, adopts migratory mesenchymal 
characteristics, enters the blood stream and might migrate to distinct body parts, where through 
reverse metamorphosis MET is able to give rise to remote metastases. 
 
EMT and epithelial polarity are closely connected, as during EMT initiation 
epithelial cell-cell junctions are reorganized and the expression pattern of polarity 
proteins is drastically changed. Upon EMT, RhoA degradation by ubiquitin ligase 
Smurf1 leads to disassembly of tight junctions in epithelial cells, and is 
characterized by subsequently reduced claudin-1 and claudin-7 expression 
(Tabaries, Siegel 2016; Moustakas, Heldin 2007), ZO-1 downregulation and 
further internalization. Furthermore, disruption of adherens junctions, 
desmosomes and cadherin switch comprise an integral part of the EMT (Knights 
et al. 2012). E-cadherin is cleaved at the plasma membrane by metalloproteases 
(i.e. MMP7 and ADAM10) and replaced by N-cadherin. The shredded C-terminal 
of E-cadherin translocates into the nucleus resulting in dissociation of E-cadherin 
– β-catenin – p120 catenin complex and AJ disruption (Grabowska, Day 2012). 
Rho GTPases also counterpart to EMT, as RhoA promotes increased cell 
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contractility and actin stress fiber formation, whereas Cdc42 plays a role in 
lamellipodia and filopodia organization (Lamouille et al. 2014).  
 Recent evidence suggests that the transforming growth factor (TGF)-β 
pathway can trigger an EMT initiation (Katsuno et al. 2013). Indeed, TGF-β was 
shown to initiate loss of cell polarity due to Par complex disassembly during EMT 
(Ozdamar et al. 2005). Although TGF-β is mostly known as a proinflammatory 
cytokine, its excrescent secretion leads to EMT activation via two interrelated 
pathways: canonical and non-canonical TGF-β pathways (Figure 2.5).  
 
 
Figure 2.5: Smad-dependent (canonical) and -independent (non-canonical) TGF-β 
pathways (Papageorgis, Stylianopoulos 2015) 
TGF-β acts through the downstream mediators to exert a vast range of biological activities during 
inflammation, EMT and cancer progression. 
 
II. Introduction 
18 
 
 TGF-β binding to its receptors leads to phosphorylation of Smad2/3, 
activating the canonical Smad-dependent pathway. It causes gene 
reprogramming by directly activating the key EMT transcription factors including 
Snail, Twist and zinc-finger E-box-binding (ZEB) proteins. 
 Snail1, the mostly studied member of Snail family, is characterized by the 
SNAG box in its N-terminus, required for transcriptional repression of CDH1 
cadherin gene by recruitment of histone deacetylases or C-terminal binding 
proteins during cancer progression. At the C-terminus Snail1 contains four zinc 
finger domains and a nuclear localization signal motif, required for 
deoxyribonucleic acid (DNA) binding and nuclear translocation, respectively. 
ZEB1 shares structural similarity with Snail1, however preliminary Snail induction 
is required to trigger ZEB1 expression, as Snail1 also contributes to NFκB 
nuclear import. Twist belongs to the basic helix-loop-helix (bHLH) family of 
transcription factors and is also able to repress the CDH1 gene, although  
indirectly via chromatin remodeling complex recruitment (Diaz et al. 2014). 
Dynamic co-interaction of Snail, Zeb and Twist proteins promote the 
downregulation of genes responsible for tight junction and adherens junction 
polarity protein processing and simultaneously enhance fibronectin, vimentin, N-
cadherin and matrix metalloproteinases expression, considered to be the 
hallmarks of a mesenchymal phenotype (Peinado et al. 2007). 
 Additionally, TGF-β induces non-Smad signaling pathways, leading to 
activation of Rho GTPases, MAP kinase (MAPK) pathways and the PI3-Akt-
mTOR pathway (Saitoh 2015; Yilmaz, Christofori 2009; Nistico et al. 2012; 
Lamouille et al. 2014; Derynck et al. 2014).  
 In the non-canonical TGF-β signaling pathway, TGF-β has been 
demonstrated to activate tumor necrosis factor (TNF)-receptor-associated factor 
6 (TRAF6). In turn, TRAF6 activates mitogen-activated protein kinases, including 
extracellular signal-related kinase (ERK) 1/2, p38 mitogen-activated kinase (p38) 
and c-Jun N-terminal kinase pathways. TRAF6 also activates the inhibitors of the 
κB (IκB) kinase (IKK) complex. IκBs phosphorylation results in their 
polyubiquitination and subsequent degradation, allowing NF-κB to translocate 
into the nucleus and activate the transcription of many κB-dependent genes 
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implicated in the regulation of apoptosis and EMT (Mu et al. 2012; Wu, Zhou 
2010).  
 Changes and deregulation in protein translation process are also 
considered to participate in cancer progression. The PI3K-Akt-mTOR pathway is 
known to regulate protein biosynthesis and cell size in mammals. TGF-β induced 
PI3K and mTOR signaling activity are demonstrated to be highly enhanced in a 
broad number of cancers, including breast and colorectal cancer. Activated Akt 
can phosphorylate many target proteins, most notably glycogen synthase kinase 
3β (GSK-3β). In turn, GSK-3β stimulates the transcription of Snail and thus acts 
indirectly as a repressor of E-cadherin expression and EMT induction (Yu, Cui 
2016; Bachelder et al. 2005).  Taken together, cell polarity is essential for the 
proper functioning of eukaryotic cells, relies on a strong interplay between 
polarity proteins and a wide variety of signaling pathways and is crucial to 
regulate tumor progression and metastatic processes. 
2.3 Hippo signaling pathway and its link to cell polarity  
 The Hippo pathway (Figure 2.6) was first described in studies of 
Drosophila that examined genes involved in tissue growth (Justice et al. 1995; 
Xu et al. 1995; Tapon et al. 2002). For some time, the Hippo pathway was 
thought to be evolutionarily conserved from flies to mammals, however, in 
mammals the Hippo signaling network seems to be more extensive and 
complicated. To date, this signaling pathway is known to control organ size by 
inhibiting cell proliferation and promoting apoptosis, and to play an important role 
in tissue repair and regeneration. Deregulation of the Hippo pathway is closely 
connected with cancer progression and metastasis, as mutations in its core 
proteins have been shown to result in overgrowth phenotype (Yu et al. 2015).   
 The core of the Hippo pathway includes several kinase cascades that 
work redundantly to regulate the activity and localization of the downstream 
effectors Yes-associated protein (YAP) and transcriptional coactivator with a 
PDZ-binding motif (TAZ) (Figure 2.6). Initially, the cascade begins with MST 
protein activation via its phosphorylation by thousand-and-one amino acid (TAO) 
protein kinases. 
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Figure 2.6: Hippo pathway signaling in mammals (adapted from Hao et al. 2014) 
The Hippo pathway is known to regulate cell size and tissue growth via several kinase cascades, 
the common goal of which is the regulation of YAP/TAZ localization via physical interaction with 
AMOT and other proteins. These kinases promote YAP/TAZ phosphorylation and nuclear 
sequestration, thus controlling and regulating gene transcription. 
 Phosphorylated MSTs together with the adaptor protein Salvador family 
WW domain-containing protein (SAV)1/WW45 are able to phosphorylate and 
activate large tumor suppressor (LATS) proteins, especially LATS1 and LATS2, 
promoting their autophosphorylation (Meng et al. 2016; Ehmer, Sage 2016). 
Afterwards, the LATS protein subset is believed to phosphorylate and inactivate 
YAP and TAZ. Phosphorylation of YAP and TAZ leads to their binding with 14-3-
3 protein binding site and causes cytoplasmic sequestration and accumulation or 
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ubiquitin-depended degradation. When the Hippo pathway is off, non-
phosphorylated YAP and TAZ translocate into the nucleus, bind the TEA domain 
(TEAD) transcription factor family and prompt expression of a wide range of 
genes that are involved in cell proliferation and migration (Yu et al. 2015; Meng 
et al. 2016). Connective tissue growth factor (CTGF), Cysteine-rich angiogenic 
inducer 61 (Cyr61) and baculoviral inhibitors of apoptosis repeat-containing 2 
(Birc2) have been shown to be direct targets induced by YAP-dependent TEAD 
activation, and to play a role in proliferation and anchorage-independent growth 
(Liu et al. 2015; Zhao et al. 2010b). Moreover, YAP and TAZ are known to 
interact with Smad2 and Smad3, connecting another transcriptional target of 
YAP plasminogen activator inhibitor 1 (Pai1) with activation of TGF-β signaling 
during tissue fibrosis and cancer (Zhao et al. 2010a).  
 Additionally, Hippo pathway activity is regulated by upstream signals. In 
Drosophila, the Mer/Ex/Kibra complex acts as an apical tumor suppressor 
complex, recruits Hpo (MST1/2 flies homolog) to the plasma membrane and 
enhances its phosphorylation, which could also influence YAP localization (Mo et 
al. 2014). In mammals, Kibra was shown to interact with aPKC and angiomotin 
family proteins (Zhang et al. 2014). AMOT was first described as a protein 
promoting endothelial cell migration and angiogenesis. However, two different 
isoforms of AMOT exhibit different functions, as only p80 was shown to promote 
cell migration and is not able to bind to YAP (Yi et al. 2013). Binding p130 AMOT 
to YAP family proteins is crucial for YAP and TAZ phosphorylation and their right 
localization to the tight junction. Furthermore, AMOT inhibits YAP-induced 
transformation and loss of cell contact inhibition in the epithelial cells. 
 Remarkably, AMOT is shown to interact through its C-terminal PDZ 
binding motif with Pals1 and Patj, maintain their proper localization and thus is 
important for the long-term TJ integrity in epithelial cells (Wells et al. 2006). The 
phosphorylation state of AMOT is also highly important and drives the 
association with Pals1/Patj at the plasma membrane, whereas the non-
phosphorylated form concomitantly induces YAP and TEAD association, 
enhances its transcriptional activation and promotes uncontrolled cell 
proliferation (Moleirinho et al. 2017). Interestingly, in MCF10A human breast 
epithelial cell line Pals1 and Patj were determined to co-precipitate with YAP. 
II. Introduction 
22 
 
This might involve AMOT proteins as well, as they were also present in pull-
downs, verified by Western Blot (Zhao et al. 2011; Varelas et al. 2010). In 
addition, AMOT is able to form a complex with Patj and by controlling GTPase 
activity regulates migration capacity of endothelial cells (Ernkvist et al. 2009). 
Recent data also identified AMOT as a novel binding partner of cadherin -11, a 
marker of EMT in prostate cancer cells. Together with  cadherin-11, AMOT could 
influence mediated migration of these cells (Ortiz et al. 2014)   
 In addition, Crb3 is considered to interact with AMOT and Merlin to 
regulate YAP- and TAZ-dependent transcription and MAP kinase signaling, 
hence Crb3 is linked to cell-density-dependent regulation of proliferation and 
cancer (Varelas et al. 2010; Zihni et al. 2014).  
 Taken together, precise control of cell-cell adhesion in combination with 
decisive physiological function and molecular interplay of polarity determinants 
with Hippo and other signaling pathways is crucial in development as well as in 
cancer progression. 
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III. Aim of the study 
 Every year the number of cancer suffering patients increases drastically, 
reflecting the biggest medical worldwide problem to date. By 2020, there will be 
approximately 15 million new cancer patients diagnosed (Bray, Moller 2006). For 
this reason, the mechanisms triggering cancer, and the basic differences 
between a 'normal' cell and cancer cells must be intensely investigated. 
 Proper regulation and maintenance of cell polarity are required for 
development and homeostasis. There is strong evidence that the disruption of 
cell polarity and loss of cell-cell adhesion are implicated in cancer growth. Two 
fundamental roles of epithelial cells contribute to tumor development: the 
regulation of asymmetric cell division and the maintenance of the apical junction 
complex (Royer, Lu 2011). 
 Several cell polarity genes have been identified as tumor suppressors in 
flies and mammals, simultaneously playing a fundamental role in cell fate 
decisions and epithelial cell polarity. Mutations of Dlg, Lgl, Scribble, deregulation 
of Par3 and Crb3 cause excessive non-controlled epithelial growth, loss of 
apical-basal polarity, enhance EMT and metastatic progression (Wodarz 2000; 
McCaffrey et al. 2012; Karp et al. 2008; Elsum et al. 2013).  
 However, little is known about the direct Crb3 interaction partner protein 
Pals1, its implication in establishment and maintenance of cell polarity as well as 
cell proliferation and migration. Hence, the present study was designed to 
assess the variety of Pals1 functions in epithelial cell polarity, with the goal of 
describing its possible implication in tumor progression. The role of Pals1 in both 
apicobasal polarity maintenance and junction formation was investigated. 
Moreover, the function of Pals1 in the Hippo pathway and TGF-β signaling 
remains perplexing. Since Pals1 is involved in E-cadherin trafficking, the next 
objective of the study was to explore the possible influence of Pals1 on cell 
migration and EMT. In addition, it was of interest to analyze the potential role of 
Pals1 in tumor growth and metastasis development in vivo. 
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IV. Materials and Methods 
4.1 Equipment 
Table 1 Equipment 
Equipment Label  Manufacturer 
Autoclave  5050 ELV  Tuttnauer  
Cell culture incubator CB 160 Binder 
Centrifuge Multifuge 3 Heraeus 
Centrifuge Microstar 12 VWR 
Chemical balance  BL 1500 S  Sartorius  
Chemiluminescence-
system  
Fusion FX 7  Vilber  
Drying chamber  Heraeus T 6200  Thermo Scientific  
Drying chamber  Heraeus UT 6120  Thermo Scientific  
Electric pipetting aid  Pipetboy  Integra  
Electrophoresis Module Eco-Mini Biometra 
Floor centrifuge Varifuge 3.0 RS Heraeus 
Freezer -20 °C GNP 3376 Liebherr 
Freezer -80 °C GFL Chest Freezer 6485 Novolab 
Heating block  Thermomixer comfort  Labnet  
Heating/shaking block Thermomixer R Eppendorf 
Imager GelDoc XR+ Biorad 
Incubator shaker  Unitron  Infors HT  
Laminar Airflow Bench LaminAir  HBB2472S Heraeus 
Laminar Flow Hood  Herasafe HS18 Heraeus 
Light microscope Eclipse TS100 Nikon 
Laser scanning 
microscope 
LSM 510 Meta Zeiss 
Light/fluorescence 
microscop 
Axiovert 200 Zeiss 
LightCycler  480 System Roche 
IV. Materials and Methods 
25 
 
4.2 Materials 
4.2.1 Consumables 
Table 2 Consumables 
Disposables Manufacturer 
96 Biosphere® Filter Tips, 0.1 – 10 µl Sarstedt 
96 Biosphere® Filter Tips, 2 – 20 µl Sarstedt 
Autoclave tape, 50 m Brand 
Cell Scraper 25 cm Sarstedt 
Cuvettes, 10 x 4 x 45 mm Sarstedt 
Delicate Task Wipes – White  Kimberly-Clark 
Folded Filters (Qual.), Ø 240 mm Sartorius  
Micro tube, 1.5 ml Sarstedt 
Microscope Cover Glasses, Ø 22 mm Thermo Scientific 
Microscope Slides, 25 x 75 x 1.0 mm Thermo Scientific 
Multiply -Pro cup, 0.2 ml Sarstedt 
Magnet stirring bar 
retriever 
MR3001 Heidolph 
Microwave  8018 E  Privileg  
pH Meter CG842 Schott 
Platform shaker  Duomex 1030  Heidolph  
Refrigerator  Medline Liebherr 
Sonicator Sonopuls HD2070 Bandelin 
Spectrometer  Nanodrop 2000  Thermo Scientific  
Table centrifuge  CT 15 RE  Hitachi  
Thermocycler  Mastercycler nexus  Eppendorf  
transilluminator  UV slider  Intas  
Vortex mixer  Vortex Genie 2  Intas  
Waterbath 3042 Koetterman 
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Nitril Extra-Sensitive Gloves Nitrisense 
Parafilm “M” Bemis 
Pipette tip, 1000 µl Sarstedt 
Pipette tip, 200 µl Sarstedt 
Pipette tip, 20 µl Sarstedt 
Pipette tip, 10 µl Sarstedt 
SafeSeal micro tube, 2 ml Sarstedt 
Serological pipette, 10 ml Sarstedt 
Serological pipette, 5 ml Sarstedt 
Serological pipette, 2 ml Sarstedt 
TC-Dish 150, Standard Sarstedt 
TC-Flask T25, Stand., Vent. Cap Sarstedt 
TC-Flask T75, Stand., Vent. Cap Sarstedt 
TC-Plate 6 Well, Standard, F Sarstedt 
TC-Plate 12 Well, Standard, F Sarstedt 
TC-Plate 24 Well, Standard, F Sarstedt 
Transfer pipette, 3.5 ml Sarstedt 
Tube, 15 ml Sarstedt 
Tube, 50 ml Sarstedt 
Gel blotting paper Roth 
Nitrocellulose membrane GE Healthcare 
96 wells light cycler plates Sarstedt 
96 wells light cycler plates sealing foils Sarstedt 
Culture-Inserts 2 Well for self-insertion Ibidi 
Cell culture insert 24 well 8.0 μm pore size Falcon 
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4.2.2 Chemicals 
Table 3 Chemicals 
Name Source 
6x Loading Dye (LD) Thermo Scientific 
Acrylamide  Roth  
Agarose  Bioenzym scientific  
Ammonium per sulfate (APS) Thermo scientific  
Ampicillin  Roth 
Bovine serum albumin (BSA) Roth  
Bromphenol blue Pharmacia Biotech 
Chloroform  Merck 
Crystal violet Roth 
Diamidino-2-phenylindol Dihydrochlorid (DAPI) Roth 
Dimethyl sulfoxide  (DMSO) Sigma  
Dithiothreitol (DTT) Roth 
Dntps (datp, dgtp, dctp, dttp)  Thermo scientific  
Ethanol  Roth  
Ethidium bromide (EtBr) Sigma 
Ethylenediaminetetraacetic acid (EDTA) Roth 
Fugene Promega 
GeneRule 1 kilo bases (kb) DNA ladder Thermo Scientific 
Glycerol  Merck  
Glycine  Merck  
Hydrochloric acid Fluka 
Isopropanol  Merck  
Kanamycin Roth 
Lysogeny broth (LB)-agar Roth 
LB-medium Roth 
Mercaptoethanol Merck 
Methanol Merck 
Methylene blue Sigma 
Monopotassium phosphate KH3PO4 Merck 
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Mowiol Calbiochem 
N,n,n’,n’-tetramethylethylenediamine (TEMED) Sigma  
PageRuler Prestained protein ladder Thermo Scientific 
Paraformaldehyde (PFA) Polysciences 
Polybrene Sigma 
Polyethylenimine (PEI) Polysciences 
Penicillin/streptomycin Sigma 
Ponceau S solution  Sigma 
Potassium acetate  Merck  
Potassium chloride  Roth  
RNase Roth 
SB431542 Sigma 
Skimmed milk powder  Sucofin  
Sodium chloride Thermo scientific 
Sodium dodecyl sulfate (SDS) Merck 
Sodium hydroxide  Merck  
Sodium phosphate dibasic Na2HPO4 Merck 
Triethylamine  Sigma 
Trizma (TRIS base) Sigma  
Trypsin Sigma 
Trypton  Becton-Dickinson  
Tween 20  Roth  
Verteporfin Sigma 
Yeast extract  Becton-Dickinson  
Zeocine  Invitrogen 
Thiazolyl Blue Tetrazolium Bromide (MTT) reagent Sigma 
Bradford Roti-Quant solution Roth 
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4.2.3 Antibodies 
Table 4 Antibodies used for Western Blot (WB) and Immunofluorescence (IF) 
Antigen  Organism  Utilization (Dilution)  Source  
Actin  Mouse  WB (1:1000)  Santa Cruz sc-47778 
aPKC (PKCζ) Rabbit WB (1:500) Santa Cruz, sc-216 
Cdc42 Rabbit WB (1:200) Santa Cruz, sc-87 
dogE-cadherin Mouse WB/IF (1:10)  DSHB #rr1 
dogZO-1 Rat IF (1:10) DSHB #R26.4C 
E-Cadherin Mouse IF (1:200) Santa Cruz, sc-21791 
E-Cadherin Mouse WB (1:1000) BD #610181 
Pals1  Rabbit  WB/IF (1:1000)  Thermo Scientific PA5-
30966 
Pals1 Mouse WB (1:100) /IF (1:200) Santa Cruz sc-365411 
Par3 Rabbit WB (1:1000) Millipore 07-330 
Par6α Rabbit WB (1:100) Santa Cruz, sc-25525 
Par6β Rabbit WB (1:500) Santa Cruz, sc-67392 
Par6γ  Rabbit  WB (1:500)  Santa Cruz, sc-85097 
Patj  Rabbit  WB (1:1000)  Millipore 07-330 
Patj Rabbit WB (1:1000) Abcam ab151257 
pYAP  Rabbit  WB (1:1000)  Cell signaling  4911 
Smooth Muscle 
Actin (SMA) 
Mouse WB (1:100) Abcam  ab7817 
Vimentin Mouse WB (1:200) Santa Cruz sc-32322 
YAP  Rabbit  WB (1:1000)/ IF (1:400) Cell signaling  4074 
 
 
Table 5 Secondary antibodies for Western Blot 
Sec. Antigen  Organism  Dilution  Source 
Anti-rabbit horseradish 
peroxidase (HRP) 
Donkey  1:10000  Invitrogen  
Anti-mouse HRP  Donkey  1:10000  Invitrogen  
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Table 6 Secondary antibodies for Immunofluorescence 
Sec. Antigen  Organism  Dilution  Source 
Alexa Fluor 488-anti Rat Goat 1:200 Life Technologies 
Alexa Fluor 488-anti Rabbit Donkey 1:200 Life Technologies 
Alexa Fluor 488-anti Mouse Donkey 1:200 Life Technologies 
Alexa Fluor 488-anti Goat Donkey 1:200 Life Technologies 
Alex Fluor a 568-anti Rabbit Donkey 1:200 Life Technologies 
Alexa Fluor 568-anti Mouse Donkey 1:200 Life Technologies 
Alexa Fluor 647-anti Rabbit Donkey 1:200 Life Technologies 
Alexa Fluor 647-anti Rat Goat 1:200 Life Technologies 
Alexa Fluor 647-anti Goat Donkey 1:200 Life Technologies 
 
4.2.4 Enzymes 
Table 7 Restriction enzymes 
Name Restriction site Buffer Source 
AscI GG/CGCGCC yellow buffer Fermentas/Thermoscientific 
BamHI G/GATCC unique buffer Fermentas/Thermoscientific 
BbsI  GAAGAC/GAAGAC  green buffer  Fermentas/Thermoscientific  
BglI GCCNNNN/NGGC orange buffer Fermentas/Thermoscientific 
BglII  A/GATCT  orange buffer  Fermentas/Thermoscientific  
EcoRI  G/AATTC  unique buffer  Fermentas/Thermoscientific  
EcoRV  GAT/ATC  red buffer  Fermentas/Thermoscientific  
HindIII A/GCTT red buffer Fermentas/Thermoscientific 
NotI  GC/GGCCGC  orange buffer  Fermentas/Thermoscientific  
PstI  CTGCA/G  orange buffer  Fermentas/Thermoscientific  
SacII CCGC/GG blue buffer Fermentas/Thermoscientific 
StuI  AAG/CCT  blue buffer  Fermentas/Thermoscientific  
XhoI C/TCGAG red buffer Fermentas/Thermoscientific 
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Table 8 Enzymes 
Name Source 
Accuzyme Polymerase New England BioLabs 
FAST- alkaline phosphatase (AP)  Thermo Scientific 
Polynucleotide kinase (PNK) Thermo Scientific 
T4 DNA Ligase Fermentas 
Taq Polymerase homemade 
 
4.2.5 Oligonucleotides  
Table 9 Short hairpin RNA (shRNA) oligonucleotides 
Name Sequence Source 
dogPals1-shRNA-1-F GATCCCGCATGGTACGCTGACATT
TGTTTCAAGAGAACAAATGTCAGC
GTACCATGC TTTTTA 
Invitrogen 
designer 
shRNA, 
Microsytnth 
dogPals1-shRNA-1-R AGCTTAAAAAGCATGGTACGCTGA
CATTTGTTCTCTTGAAACAAATGTC
AGCGTACCATGC GG 
Invitrogen 
designer 
shRNA, 
Microsytnth 
dogPals1-shRNA-2-F GATCCCAGAGGATAGTAGACAAG
TTCTTTCAAGAGAAGAACTTGTCT
ACTATCCTCT TTTTTA 
designed by 
DSIR shRNA 
tool, 
Microsynth 
dogPals1-shRNA-2-R AGCTTAAAAAAGAGGATAGTAGAC
AAGTTCTTCTCTTGAAAGAACTTG
TCTACTATCCTCT GG 
designed by 
DSIR shRNA 
tool, 
Microsynth 
hPals1-shRNA-1-F GATCCCGCCAGTTCATCATAAGGA
AGGTTCAAGAGACCTTCCTTATGA
TGAACTGGCTTTTTA 
designed by 
DSIR shRNA 
tool, 
Microsynth 
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hPals1-shRNA-1-R AGCTTAAAAAGCCAGTTCATCATA
AGGAAGGTCTCTTGAACCTTCCTT
ATGATGAACTGGCGG 
designed by 
DSIR shRNA 
tool, 
Microsynth 
hPals1-shRNA-2-F GATCCCGCTACAGTTCGTAATGAA
ATGTTCAAGAGACATTTCATTACG
AACTGTAGCTTTTTA 
designed by 
DSIR shRNA 
tool, 
Microsynth 
hPals1-shRNA-2-R AGCTTAAAAAGCTACAGTTCGTAA
TGAAATGTCTCTTGAACATTTCATT
ACGAACTGTAGCGG 
designed by 
DSIR shRNA 
tool, 
Microsynth 
 
Table 10 Guide RNA (gRNA) sequences for CRISPR/Cas9 gene deletion 
Name Sequence Source 
dogPals1-CRISPR1-F CACC  
GGCGTAGGCGAGAGGAAG
AA 
CRISPR 
design tool, 
Microsynth 
dogPals1-CRISPR1-R AAAC  TTCTTCCTCTCGCCTACGCC CRISPR 
design tool, 
Microsynth 
hPals1-CRISPR1-F CACC  
GCCCTGGAGATTTGGGCACC 
CRISPR 
design tool, 
Microsynth 
hPals1-CRISPR1-R AAAC  
GGTGCCCAAATCTCCAGGGC 
CRISPR 
design tool, 
Microsynth 
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4.2.6 Primers for quantitative RT–PCR 
Table 11 Primers for quantitative RT–PCR 
Gene name Primer name Sequence Source 
dogSnail1 
(231 bp) 
dogSnail1-F AAGATGCACATCCGA
AGCCA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer-
BLAST 
NCBI, 
Microsynth 
 dogSnail1-R GGAGAAGGTTCGGG
AACAGG 
dogZEB1 
(295 bp) 
dogZEB1-F CAGTCCGGGGGTAAT
CGTAA 
 dogZEB1-R TTTGCCGTATCTGTG
GTCGT 
dogCyr61 
(116 bp) 
dCyr61-F CAATGACAACCTTGA
ATGCC 
 dCyr61-R TCTTGGTCTTGCTGC
ATTTC 
dogCTGF 
(126 bp) 
dCtgf-F ATGTGCCTCCTCTTT
GGAGT 
 dCtgf-R AGAACTTGACCCAGC
CTCAT 
dogBirc2 
(124 bp) 
dBirc2-F CTATTACGTGGGTCG
CAATG 
 dBirc2-R CAAGAACTCACACCT
GGGAA 
dogPai-1 
(134 bp) 
dPai1-F GTGGAGAGAGCCAG
GTTCAT 
 dPai1-R CCGTTGAAGTAGAGG
GCATT 
dogGAPDH 
(125 bp) 
dGapdh-F AGTGGATATTGTCGC
CATCA 
 
 dGapdh-R TGACAAGTTTCCCGT
TCTCA 
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hSnail1 
(237 bp) 
hSnail1-F AAGATGCACATCCGA
AGCCA 
 hSnail1-R CATTCGGGAGAAGGT
CCGAG 
hZEB1 
(242 bp) 
hZEB1-F AGATCAAAGACATGT
GACGCAG 
 hZEB1-R TGAGTCCTGTTCTTG
GTCGC 
hCyr61 
(265 bp) 
hCyr61-F GAAGCGGCTCCCTGT
TTTTG 
 hCyr61-R TGGTTCGGGGGATTT
CTTGG 
hCTGF 
(285 bp) 
hCtgf-F GTGTGCACCGCCAAA
GATG 
 hCtgf-R AAACGTGTCTTCCAG
TCGGT 
hBirc2 
(297 bp) 
hBirc2-F CTGGCCATCTAGTGT
TCCAGT 
 hBirc2-R TGAATAATTGGTGGG
TCAGCAT 
hPai-1 
(257 bp) 
hPai1-F GACCTCAGGAAGCC
CCTAGA 
 hPai1-R ACTGTTCCTGTGGGG
TTGTG 
hTwist1 
(244 bp) 
hTwist-F TCTCGGTCTGGAGGA
TGGAG 
 hTwist-R TTTTAAAAGTGCGCC
CCACG 
hLamine A/C 
(507 bp) 
hLam A/C-F CTCGTCGTCCTCAAC
CACAGT 
 hLam A/C-R TGCGTACGGCTCTCA
TCAACT 
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4.2.7 Sequencing primers and cloning vectors 
Table 12 Sequencing primers for cloning vectors 
Vector name Primer Sequence Source 
pSuperior.puro pSuperior-
copy-seq-F 
CTCCCCTACCCGGTAGAA Microsynth 
pX330-U6-
Chimeric_BB-
CBh-hSpCas9 
px-seq-R CGTCAATGGAAAGTCCCTATT
GGCGT 
Microsynth 
pSpCas9(BB)-
2A-Puro 
(PX459) V2.0 
px-seq-R CGTCAATGGAAAGTCCCTATT
GGCGT 
Microsynth 
CWG CMV-seq-F GGCGTGTACGGTGGGAGG Microsynth 
pLX302 CMV-seq-F GGCGTGTACGGTGGGAGG Microsynth 
pENTR M13-seq-F CGTTGTAAAACGACGGCCAG Microsynth 
pENTR M13-seq-R CAGGAAACAGCTATGAC Microsynth 
 
Table 13 Cloning vectors 
Vector 
name 
Backbone 
size (bp) 
Vector 
type 
Bacterial 
resistance 
in E.coli 
Selectable 
markers 
Source 
pSuperior.puro 4354 Mammalian 
Expression, 
RNAi 
Ampicillin Puromycin Oligoengine 
pX330-U6-
Chimeric_BB-
CBh-hSpCas9 
8854 Mammalian 
Expression, 
CRISPR 
Ampicillin Zeocine Addgene, 
Feng 
Zhang lab  
pSpCas9(BB)-
2A-Puro 
(PX459) V2.0 
9200 Mammalian 
Expression, 
CRISPR 
Ampicillin Puromycin Addgene, 
Feng 
Zhang lab 
CWG 6194 Mammalian 
Expression 
Ampicillin Neomycin 
(G418) 
Homemade 
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pLX302 9573 Mammalian 
Expression, 
Lentiviral; 
Gateway 
Destination 
vector 
Ampicillin  Puromycin Addgene 
pENTR 2351 Gateway 
entry vector 
Kanamycin - Thermo 
Fisher 
Scientific 
 
4.2.8 Kits 
The kits shown in the following table were always performed according to their 
instructions. 
Table 14 Commercially available kits 
Kit Utilization Source 
Nucleo Bond® PC 20/100 Midi-preparation Magery-Nagel 
Nucleo Spin®Gel and 
PCR Clean-Up 
PCR purification Magery-Nagel 
qScriptTM cDNA Synthesis 
Kit 
cDNA Synthesis QuantaScienceTM 
TRIzol®Reagent  RNA-preparation lifetechnologiesTM 
RNeasy Mini Kit RNA-preparation Qiagen 
Western Blot Detection Kit Developing Western 
Blot 
Advansta 
SensiFAST SYBR® No-
ROX Kit 
RT-PCR Bioline 
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4.2.9 Cell culture media and additives 
Table 15 Cell culture media and additives 
Name Source 
Dulbecco’s Modified of Eagle’s Culture Medium  
(DMEM) with 4.5 g/l glucose 
Sigma 
Roswell Park Memorial Institute Culture medium  
(RPMI) 1640 
Sigma 
Fetal calf serum Life technologies 
L-glutamine, 200 mM Lonza 
Penicillin/Streptomycin, 10.000 U/ml + 10.0000 μg/ml Sigma 
Puromycine Sigma 
Neomycin (G418) Sigma 
Zeocin Invitrogen 
 
4.2.10 Solutions and reagents 
Solutions, buffer and media are produced with sterile H2O and, if necessary, 
consecutively autoclaved or sterile filtered. The following list contains the 
composition of all homemade buffers and solutions, which were used. Unless 
otherwise stated, the following solutions and buffers were stored at room 
temperature (RT). 
Table 16 List of all homemade buffers and solutions  
Name            Composition 
10 %  Tween 20         41 mM  tween 
2 - Yeast extract trypton agar (YTA) 16 %  
10 %  
5 %  
ad 
tryptone  
yeast extract 
NaCl  
H2O 
stored at 4°C 
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5x SDS loading dye 250 mM  
30 %  
10 %  
0.02 %  
5 %   
tris base-HCl (pH 6.8)  
glycerol 
SDS  
bromophenol blue  
β-mercaptoethanol 
stored at -20°C 
6-DNA loading dye 10 mM 
0.03 % 
tris base-HCl 
bromophenol blue  
Ammonium persulfate  10 % 
ad 
APS 
H2O 
Ampicillin 1 g  
10 ml  
ampicillin  
H2O 
stored at 4°C 
Blocking buffer for  
immunofluorescence 
 
5% 
PBTw (pH 7.4) 
BSA 
Blocking buffer for Western Blot  
0.1 %  
2.5 % 
5 %  
ad 
Tris-buffered saline (TBS) 
Tween 20 
BSA 
milk powder  
H2O (pH 7.5) 
stored 4°C 
Buffer TE 1x pH 8.0 5 ml  
1 ml 
494 ml 
Tris base-HCl  
EDTA 
H2O 
Crystal Violet 0.1 % 
10 % 
ad 
crystal violet 
EtOH  
H2O 
Freezing medium 60 % 
30 % 
10 %  
fresh medium  
Fetal calf serum (FCS) 
DMSO 
Kanamycin 500 mg 
10 ml 
kanamycin  
H2O 
stored 4°C 
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Laemli buffer 5x 0.01 %  
60 mM  
5 %  
2 %  
10 %  
bromophenol blue  
tris base-HCl  
β-mercaptoethanol  
SDS  
glycerine 
stored 4°C 
LB- medium  1 %  
0.5 %  
1 %  
ad 
trypton  
yeast extract 
NaCl  
H2O 
stored 4°C 
LB0 Plates 10% 
5% 
5% 
15% 
tryptone 
yeast extract 
sodium chloride 
agar agar 
pH 7.0 
LBamp Plates   
100 mg/ml 
LB0 Plates 100 mg/ml  
ampicillin 
LBkana Plates   
50 mg/ml 
LB0 Plates 50 mg/ml  
kanamycin 
Lysis buffer  
0.2 % 
0.2 % 
0.2 % 
 
0.2 % 
TNT buffer (pH 7.5) 
Pepstatin A 
Aprotinin 
Phyenylmethylsulfonylfluorid 
(PMSF)  
Leupeptin 
Mild stripping buffer  200 mM  
1 %  
1%  
ad  
 
glycine  
Tween 20  
SDS  
H2O  
pH 2.2 
Mowiol  0.4 g/ml Mowiol 
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1 g/ml 
2% 
Glycerol 
Tris-HCl (0.2 M) 
P1 mini buffer 50 mM  
10 mM  
100 µg  
ad  
 
tris base-HCl (pH 8.0)  
EDTA  
RNase A 
H2O  
stored at 4 °C 
P2 mini buffer 200 mM  
1 %  
ad  
NaOH  
SDS  
H2O 
P3 mini buffer 3 M  
ad  
potassium acetate  
H2O 
stored at 4°C 
Paraformaldehyde  3.7 % 
in 
paraformaldehyde 
Phosphate buffered saline 
PBS (pH 7.4) 
stored at -20°C 
PBS 10x pH 7.4 1.37 M  
27 mM  
100 mM  
18 mM  
5 mM  
ad  
NaCl 
KCl  
Na2HPO4 x 2 H2O  
KH2HPO4 
glucose 
H2O 
PBTw  
0.1 % 
PBS (1x) 
Tween 20 
PNK buffer 10x 500 mM 
100 mM 
50 mM 
1mM 
1 mM 
Tris-HCl (pH 7.6) 
MgCl2  
DTT 
ADP 
spermidine 
Ponceau-solution 0.1 %  ponceau S  
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5 %  glacial acetic acid 
SDS loading dye 2x 2.5% (w/v) 
25 % 
125 mM 
0.01 % 
100 mM 
SDS 
Glycerol 
tris-HCl 
bromophenol blue 
dithiothreitol 
SDS-running buffer pH 8.3 380 mM  
50 mM  
0.2 %  
ad  
glycine  
tris base 
SDS  
H2O 
stored at 4°C 
T4 ligase buffer 10x 400 mM 
100 mM 
100 mM  
5 mM  
Tris-HCl 
MgCl2  
DTT 
Adenosine triphosphate 
(ATP) 
TAE buffer 40 mM  
1 mM  
0.1 %  
ad  
tris base-acetate  
EDTA 
glacial acetic acid  
H2O 
TBS (pH 7.6) 150 mM  
3 mM  
25 mM  
ad  
NaCl  
KCl 
tris base  
H2O 
TBS-T  
0.1 %  
TBS 
tween 20 
TNT buffer 100 mM  
150 mM  
0.1 %  
tris base-HCl  
NaCl  
tween 20 
stored at 4°C 
Transfer buffer 200 mM  
25 mM  
glycine  
Tris base-HCl (pH 6.8)  
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20 %  
ad 
methanol  
H2O 
stored 4°C 
4.2.11 Data bases and software  
Table 17 Data bases and software 
Data bases and software Utilization 
Citavi Citation program 
DnaDynamo Theoretical cloning 
IMAGEJ Editing pictures, WB Quantifications  
LSM Image Browser Imaging editor for LSM pictures 
NCBI Database for human genes 
Microsoft Word 2013 Writing program 
Microsoft Power Point 2013 Editing pictures 
Thermo Insight Measurement of protein concentration 
Fusion Chemiluminescence imaging 
GelDoc Biorad Image Analysis of agarose gels 
LightCycler 480 software Software for analyzing Real-Time PCR 
data 
NanoDrop 2000 DNA/RNA measurement 
DSIR  shRNA target design 
E-CRISPR CRISPRs: designing gRNA 
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IV.III Methods 
4.3 Cloning 
4.3.1 Oligonucleotide hybridization for shRNA (gRNA) 
 To obtain stable cell line showing the downregulation or knockout of the 
gene of interest, the shRNA vectors/ gRNA CRISPR vectors have to be 
constructed. First, the most promising shRNA’s/ gRNA are chosen using the 
shRNA/gRNA designing tools, as it is an essential step for identification of active 
shRNA/gRNA sequences. Than short pieces of synthetic single-stranded DNA 
with defined chemical structure, complementary to the target mRNA/gDNA, have 
to be synthetized and fused to double-stranded subsequent shRNA/gRNA. This 
short RNA molecule can afterwards bind target mRNA/gDNA and inactivate it, 
which in turn causes sequence-specific gene silencing or knockout.  
 Oligonucleotide hybridization implicates oligonucleotide phosphorylation, 
denaturation of all secondary structures and final annealing of complementary 
strands. 
 Reagents 
 T4 PNK  
 10x T4 Polynucleotide Kinase reaction buffer 
 ATP 10 mM 
Procedure 
1. For each shRNA/ gRNA it was mixed together in PCR-tubes 
20 µl total volume: 
8 µl oligo F (100µM) 
8 µl oligo R (100µM) 
2 µl 10 x PNK  buffer 
1 µl 10 mM ATP 
1 µl PNK 
2. Further ligation was performed according to the program below 
1 h - 37 °C 
5 min - 95 °C 
10 min - cool down from 95 to 20 (-1°C, 70 cycles) 
20 min - 65 °C 
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4.3.2 Polymerase chain reaction (PCR)  
 PCR is a method used to amplify a selected piece of DNA. Utilizing the 
enzyme, called polymerase, the DNA fragment can be multiplied from the 
template - dsDNA containing the sequence of the gene of interest. To start the 
reaction, the dsDNA has to be uncoiled to get ssDNA, applying a drastic 
increase of temperature. This step called denaturation. Afterwards the 
temperature is reduced, allowing the 5’-3’ forward and 3’-5’ reverse primers to 
bind to ssDNA and then the polymerase can elongate the defined fragment. 
These three steps are repeated 20-40 times giving subsequently specific DNA 
fragment. In this thesis conventional PCR technic was used to obtain DNA 
sequence, encoding the gene of interest, to rescue the knockdown (KD) or 
knockout (KO) mutants. 
Reagents 
 10x Taq polymerase buffer 
 dNTPs (dATP, dCTP, dGTP and dTTP) 10 mM 
 Taq polymerase 
 Forward primer 50 μM 
 Reverse primer 50 μM 
 DNA template 50-500 ng 
Procedure 
1. For each PCR reaction it was mixed in PCR-tubes 
25 µl total volume: 
16  µl  H2O 
2.5 µl 10x Taq polymerase buffer 
1 µl Primer forward 
1 µl Primer reverse 
1 µl  dNTPs 
1 µl Taq polymerase 
0.5 µg Template 
 
2. Further PCR was performed according to the program below 
5 min - 95 °C Initial denaturation 
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30 s  - 95 °C Denaturation 
   30 s  - 55 °C Annealing x 30 cycles 
1 – 2 min/kb - 72 °C Elongation 
 
15 min - 72 °C Final elongation 
Infinite - 10 °C storage 
4.3.3 Vector preparation 
 To allow subsequent ligation of the insert into the certain vector, it has to 
be accordingly “prepared”. Cloning by restriction digest is one of the most 
common methods in molecular biology. To be able to clone the desired insert 
into a cloning or expression vector, both have to be digested or formerly 
designed (i.e. shRNA) to create compatible ends. It is highly recommended to 
cut the vector with two enzymes; otherwise, the risk of re-ligation is pretty high. 
To minimize it, the ends of the vector have to be dephosphorylated using alkaline 
phosphatase. To remove the nicked, supercoiled and undigested rests, the 
vector after digestion and dephosphorylation has to be purified by agarose gel 
electrophoresis.  
4.3.4 Plasmid digestion 
Reagents 
 Restriction enzymes (BglII+HindIII for pSuperior.puro, BbsI 
and EcoRI for px330 and px459, KpnI for plx302 and CWG-
TO)  
 Compatible restriction buffer 10x 
 Plasmid 
Procedure 
In order to cut off the vector 1 µg plasmid, 4 µl buffer and 2 µl enzyme were 
mixed well and the samples were then incubated over night at 37°C. On the next 
day, the digested vector was purified by methylene-blue stained agarose gel. 
4.3.5 Agarose gel electrophoresis 
 Gel electrophoresis is used after the PCR to isolate PCR-products, after 
the plasmid digestion to purify the digested vector and for control digestion of the 
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plasmid DNA. The agarose gels for PCR-products and vector purification are 
stained with methylene blue, whereas the gels showing the result of plasmid 
DNA control digestion are stained with ethidium bromide (EtBr). These chemical 
agents incorporate into dsDNA and may then be visible in the gel (methylene 
blue) or visualized under ultraviolet light (EtBr). To determine the molecular size 
of the DNA product molecular weight markers are used.  These markers contain 
a mixture of proteins of known sizes and are stained as well.  
Reagents 
 Agarose 
 1 x TAE buffer 
 Ethidium bromide (10 mg/ml) 
 6 x DNA Loading Dye Solution 
 Gene Ruler 1kb DNA ladder 
Procedure 
1. 0.7 g agarose was boiled with 70 ml 1 x TAE-Buffer 
2. 20 µl of ethidium bromide were added to the melted agarose 
3. Gel was then poured in the gel holder and the gel comb was inserted 
4. The gel had to polymerize for 1 h at room temperature 
5. The gel was placed in the gel box (electrophoresis unit) and fully covered 
with 1x TAE-Buffer; the gel comb was removed  
6. 4 µl of the loading dye were added to 20 µl of each sample 
7. 10 µl of the DNA ladder standard solution and the samples were then 
placed in the wells 
8. The electrophoresis was performed for approximately 30 min at 130 V 
9. The bands were visualized with methylene blue or under UV light, when 
EtBr was added 
4.3.6 Purification of vector/PCR product 
 After the methylene-blue staining, the required bands were cut out as 
accurate as possible and transferred into a 1.5 ml Eppendorf tubes. Afterwards 
the desired DNA fragments were purified with Nucleo Spin®Gel and PCR Clean-
Up Kit according to the manufacturer instructions. 
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4.3.7 Vector dephosphorylation/PCR product digestion 
In order to avoid the re-ligation of the digested and purified vector, the 5’ end has 
to be dephosphorylated. To allow the insertion of the PCR product into the 
purified vector the insert was digested to obtain the sticky ends. 
Reagents 
 Purified vector/ PCR product 
 FAST-AP/ restriction enzymes 
 10x FAST-AP buffer/ 10x appropriate restriction enzyme buffer 
Procedure 
1. 26 μl of the purified vector/ PCR product were mixed with 3 μl of the 
appropriate buffer and 1 μl FAST-AP/ 2 μl of each restriction enzyme  
2. The mixture was incubated for 30 minutes to 2 hours at 37°C before the 
enzymes were inactivated for 20 minutes at 75 °C 
4.3.8 Ligation 
In the last step of the cloning procedure, the ligation of insert and vector 
followed.  
 Reagents 
 T4 Ligase 
 T4 Ligase buffer 
 Vector 
 Insert 
 Procedure 
Three ligations were set up according to the table 18. The ligations were 
incubated 3 hours at RT or overnight at 16 °C and then transformed into cells 
as explained in 4.3.10.  
 
1. The ligation mixture was set up according to the Table 18. 
Table 18 Setup for insert - vector ligation 
 control ligation 1:1 ligation 1:4 
H2Odd 17.3 µl 16.8 µl 15.3 µl 
T4 ligase buffer 2 µl 2 µl 2 µl 
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Insert 0.5 µl 0.5 µl 0.5 µl 
Vector - 0.5 µl 2 µl 
T4 ligase 0.2 µl 0.2 µl 0.2 µl 
 
4.3.9 CRISPR/Cas9 cloning 
In contrary to the normal cloning method, the Clustered regularly interspaced 
short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9) 
cloning underlines the combination of cutting of vector technique and 
simultaneous ligation process. 
Reagents 
 Px330/459 plasmid 
 Annealed phospho-oligos F+R 
 T4 ligation buffer 
 BbsI 
 T4 ligase 
Procedure 
1. For each gRNA, the reaction mix was prepared in an Eppendorf tube 
50 ng  px330/px459 plasmid 
0.5 μl annealed phospho-oligo F+R 
1 μl 10x T4 ligation buffer 
0.5 μl  BbsI 
0.5 μl  T4 ligase 
up to 10 μl H2O 
 
2. Further ligation/digestion was performed according to the program 
below 
5 min - 37 °C 
5 min - 23 °C 
           5 min - 37 °C  
           5 min - 23 °C x 30 cycles 
Infinite  - 10°C 
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4.3.10 Transformation of chemically competent E. coli cells – DH5 
alpha 
 The goal of this method is to transfer a desired ligated plasmid into 
bacterial cells in order to cultivate them and thereby amplify the amount of the 
plasmid. In this study, only E.coli DH5alpha cells were used for transformation. 
By CaCl2 or MgCl2 incubation, the cells became competent and thus the cell 
membrane was permeable for plasmid DNA. 
 Regents 
 Competent E. coli cells – DH5 alpha 
 Vector (ligation mix) 
 LB-plates 
Procedure 
1. DH5 alpha competent E. coli cells were thawed on ice 
2. 20 μl of plasmid DNA were added to the cell mixture and flicked 
3. The mixture was placed on ice for 30 min 
4. Heat shock was performed exactly at 42 °C for exactly 1 min  
5. The mixture was placed on ice for 5 min 
6. 200 μl of prewarmed LB-medium were pipetted into the mixture  
7. The mixture was shacked for 30 min at 37°C to allow to double and to 
recover 
8. The mixture was spread onto a selection plate and incubated 
overnight at 37°C 
4.3.11 DNA-preparation 
 The main goal of molecular cloning is to assemble recombinant DNA and 
introduce it into the host organisms. The transformation process is used to 
amplify vector DNA and to select the cells containing the vector of interest. Thus, 
the first part of DNA preparation is picking the cells form plate. Afterwards picked 
colonies were inoculated and amplified by adding 2 ml LB-medium. After growing 
overnight, the Mini-preparation and following Midi-preparation were used to 
isolate desired plasmid DNA. 
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4.3.12 Mini-preparation 
The Mini-preparation of the plasmid DNA is a small-scale isolation of plasmid 
DNA from bacteria to test the construct for its propriety. 
 Reagents 
 P1 mini-buffer 
 P2 mini-buffer 
 P3 mini-buffer 
 100 % EtOH 
 70 % EtOH 
Procedure 
1. 1.5 ml of overnight culture were poured into the tubes and centrifuged 
for 1 min at 6000 rpm  
2. The pellet was resuspended in 100 µl buffer P1 
3. 200 µl of P2 buffer were added 
4. Following addition of 150 µl P3 buffer, the tubes were inverted 3-4 
times  
5. The samples were centrifuged for 6 min at 14000 rpm at 4°C  
6. New tubes with 900 µl of 100 % EtOH were prepared 
7. The supernatant was transferred into the new tubes with EtOH and 
mixed 
8. The samples were centrifuged for 12 min at 15000 rpm at 4 °C 
9. The pellets were washed with 1 ml 70% EtOH and centrifuged for 3 
min at 14000 rpm  
10. The pellets were dried at 65°C in incubator and dissolved in 25 µl 
H2Odd 
4.3.13 Restriction digestion 
 The restriction digestion is used after mini-preparation, in order to verify 
the accuracy of molecular cloning. Restriction enzymes are cutting the purified in 
4.3.12 plasmid DNA in a site-specific manner. After the separation by agarose 
gel, different band pattern should occur depending on the assembly of the insert. 
On the one hand, it should be proved whether the insert was assembled into the 
vector and on the other hand whether the direction of the insert is correct. Thus, 
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the specific restriction enzymes have to be chosen. For this reason, it is 
important to find unique restriction sites, which occur in the insert and in the 
cloned vector as well. After determination of appropriate restriction enzymes, the 
following master mix has to be prepared per each Mini-purified plasmid DNA 
(Table 19). 
Table 19 Master mix composition for restriction digest  
 Amount 
Appropriate buffer  2 μl  
Each restriction enzyme  0.3 μl  
ad H2O  20 μl  
 
For CRISPR/ Cas9 (px330/459) and pSuperior.puro vectors, upon successful 
cloning of gRNA or shRNA, BbsI and BglII cutting sites respectively are 
destroyed, so those purified plasmids cut by these enzymes will not contain the 
insert fragment, thus making the restriction digestion for these vectors and 
further positive clone selection much easier.    
The control digestion of the purified Mini-samples is followed by EtBr-containing 
agarose gel electrophoresis and consecutive band pattern could be verified in 
transilluminator under UV light.  
Restriction digestion enzymes for each plasmid and band patterns are shown in 
Table 20. 
Table 20 Restriction digestion enzymes and band patterns for each plasmid 
Plasmid Restriction enzymes Expected positive band 
sizes 
pSuperior.puro for all 
shRNAs‘s  
PstI, BglII ca. 4600 bp 
pX330-U6-Chimeric_BB-
CBh-hSpCas9 for 
gRNA’s 
BbsI, EcoRI ca. 9000 bp 
pSpCas9(BB)-2A-Puro 
(PX459) V2.0 for gRNA’s 
BbsI, EcoRI ca. 8500 bp+700 bp 
pLX302 for over-
expression 
XhoI ca. 7000 bp+2000 bp+ 
650 bp 
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pENTR gateway StyI, NotI ca. 1800 bp+2800 bp 
 
Afterwards, the positive clones could be inoculated for further Midi-preparation. 
For this purpose, 55 ml LB-medium and 55 μl of antibiotics 
(ampicillin/kanamycin) were filled in a volumetric flask and after that 10 μl of the 
positive clones of the Mini-preparation were added. The culture was incubated 
overnight at 37 °C with continuous agitation. 
4.3.14 Midi-preparation and sequencing 
 After overnight incubation, the Midi-cultures were spun down and purified 
with Nucleo Bond® PC 20/100 kit according to the manufacturer instructions and 
sent to Microsynth AG for further sequencing. 
  
4.4 Cell culture 
 4.4.1 Cell line propagation 
The cell lines and media used are listed in Table 21. Cells were 
maintained in standard medium supplemented with 100 units/ml penicillin, 100 
µg/ml streptomycin and 10 % fetal calf serum (FCS), which is inactivated by 
centrifuging at 3000 g 10 min prior to addition to the medium. All cell lines were 
grown at 37 °C in a cell incubator in a 5 % carbon dioxide/100 % humidity 
atmosphere. When confluence was reached, cells were sub-cultured upon 
trypsinisation. After detachment, the cells were resuspended in standard medium 
and seeded at the desired dilution in the new culture flasks. For storage in liquid 
nitrogen, the cells were frozen in a solution composed of 60 % nutrition medium, 
30 % FCS and 10 % DMSO. 
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Table 21 Cell lines and corresponding culture media with supplements 
Cell line  Origin  Characteristics  Medium  
HCT116  
ATCC: CCL-247 
Human,  
Colorectal 
carcinoma  
Dukes D stage 
Epithelial,  
adherent  
DMEM 4.5 g/l 
Glucose + 10 % 
FCS  
HCT116 Scrbld Human,  
Colorectal 
carcinoma, with a 
nonsense / 
scrambled 
sequence as 
negative control 
Epithelial,  
adherent  
DMEM 4.5 g/l 
Glucose + 10 % 
FCS + 0.5 μg/ml 
puromycine 
HCT116  
hPals1 sh1 
Human,  
colorectal 
carcinoma stable 
cell line showing 
the 
downregulation of 
Pals1 expression 
by hPals1 
shRNA1 
Epithelial,  
adherent  
DMEM 4.5 g/l 
Glucose + 10 % 
FCS + 0.5 μg/ml 
puromycine 
HCT116  
hPals1 sh2 
Human,  
colorectal 
carcinoma stable 
cell line showing 
the 
downregulation of 
Pals1 expression 
by hPals1 
shRNA2 
Epithelial,  
adherent  
DMEM 4.5 g/l 
Glucose + 10 % 
FCS +0.5  μg/ml 
puromycine 
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HCT116  
ΔhPals1 
 
Human,  
colorectal 
carcinoma, 
showing the 
knockout of Pals1 
 
 
  
Epithelial,  
adherent  
DMEM 4.5 g/l 
Glucose + 10 % 
FCS +100  μg/ml 
zeocine 
HCT116 
ΔhPals1+ hPals1 
Human,  
colorectal 
carcinoma, 
showing the 
rescue of Pals1 
expression in a 
HCT116 ΔhPals1 
cell line 
Epithelial,  
adherent  
DMEM 4.5 g/l 
Glucose + 10 % 
FCS + 0.5 μg/ml 
puromycine 
MDCK 
ATCC: CCL-34 
 
Canine kidney, 
normal, 
non-cancer 
Epithelial,  
adherent 
 
DMEM 4.5 g/l 
Glucose + 10 % 
FCS 
MDCK Scrbld Canine kidney cell 
line, with a 
nonsense / 
scrambled 
sequence as 
negative control 
Epithelial,  
adherent 
DMEM 4.5 g/l 
Glucose + 10 % 
FCS + 1 μg/ml 
puromycine 
MDCK dogPals1 
sh1 
Canine kidney cell 
line, showing the 
downregulation of 
Pals1 expression 
by dogPals1 
shRNA1 
Epithelial,  
adherent 
DMEM 4.5 g/l 
Glucose + 10 % 
FCS + 1 μg/ml 
puromycine 
MDCK dogPals1 
sh2 
Canine kidney cell 
line, showing the 
Epithelial,  
adherent 
DMEM 4.5 g/l 
Glucose + 10 % 
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downregulation of 
Pals1 expression 
by dogPals1 
shRNA2 
FCS + 1 μg/ml 
puromycine 
MDCK 
ΔdogPals1 
Canine kidney cell 
line, showing the 
knockout of Pals1 
Epithelial,  
adherent 
DMEM 4.5 g/l 
Glucose + 10 % 
FCS + 1 μg/ml 
puromycine 
DLD1 
ATCC: CCL-221 
 
Human,  
Colorectal 
carcinoma, 
Dukes C stage 
Epithelial,  
adherent 
RPMI + 10 % FCS 
DLD1 ΔhPals1 Human,  
colorectal 
carcinoma, 
showing the 
knockout of Pals1 
Epithelial,  
adherent 
RPMI + 10 % FCS +  
1 μg/ml puromycine 
HEK 293T 
ATCC:CRL-3216 
Human, 
embryonic kidney 
Epithelial,  
adherent 
DMEM 4.5 g/l 
Glucose + 10 % 
FCS 
 
 4.4.2 Transfection 
 Transfection is a powerful biological tool that enables the study of the 
particular gene role and its products in the cell.  Mammalian cell transfection is a 
technique commonly used to deliver and express exogenous DNA or RNA in a 
host cell line and genetically modify it. There are two primary categories of cell 
transfection: transient and stable. Unlike transient transfection, in which 
introduced DNA persists in cells only for some days, stable transfection 
introduces foreign nucleic acid into cells for a long term and usually has a marker 
gene for selection, to maintain the permanent DNA integration into the host 
genome. Genetically modified cell lines, used in this thesis, are stable cell lines 
and were created either by conventional liposome/lipid-mediated transfection or 
by lentivirus-mediated gene delivery (transduction). 
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 4.4.3 Conventional liposome/lipid-mediated transfection 
 Liposomes are synthetic analogs, characterized by the hydrophobic and 
hydrophilic regions. Under aqueous conditions, these molecules can encapsulate 
free nucleic acid, fuse with a cell membrane and deliver DNA or RNA into the 
cell. As an alternative to liposomes, some lipids and polymers are able to form 
micelles with encapsulated foreign nucleic acid and also bring them into cultured 
cells. All genetically modified cell lines in this thesis, showing the knockdown or 
knockout of the gene of interest were created as follows. 
 Reagents 
 DMEM w/o FCS and any additives 
 Fugene HD Transfection Reagent 
 Plasmid 
Procedure 
1. One day before transfection the cells were counted in the Neubauer 
chamber, adjusted to 300 000 cells/ml and seeded one ml per well in a 6-
well plate 
2. 150 μl of DMEM medium w/o FCS were added to a sterile Eppendorf tube 
together with 1 μg of the plasmid and vortexed 
3. 3 μl of Fugene (DNA: Fugene = 1:3) were added, vortexed briefly and the 
mix was incubated for 15 min at RT 
4. The Fugene/DNA mixture was added drop-wise to the cells 
5. Next day the cells were transferred to a bigger plate and selection 
antibiotics were added. The medium was replaced every 3-4 days till the 
colonies grew 
6. The colonies were picked and verified for an expected phenotype via 
Western blot or immunofluorescence 
 4.4.4 Lentivirus-mediated gene delivery (transduction) 
 The use of viruses to deliver the plasmid DNA into the cell is an 
alternative and more efficient method for mammalian cell transfection, as not 
every cell line is equally good amendable for conventional transfection. In this 
study, lentiviral transduction was used to create the rescue of the mutant 
knockout phenotype by re-expression of the corresponding gene. 
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Reagents 
 HEK 293 T cells 
 PEI 1 mg/ml in H2O 
 DMEM Medium w/o FCS and additives 
 Lentiviral Plasmid  
 Viral envelope expressing plasmid pMD2.G 
 Lentiviral packaging plasmid pCMVΔR8.2 
 Polybrene 100 mg/ml in PBS 
 Procedure 
I. Virus preparation 
 1. HEK 293T cells were plated one day before the transfection so that 
they were approximately 80% confluent a day after 
 2. Next morning, the medium was replaced with 20 ml of DMEM without 
FCS and antibiotics 
 3. DNA was mixed together with DMEM and PEI in a final volume of 
1380 µl 
  DMEM Ø FCS  to 1380 µl 
  Lentiviral Plasmid   15 µg 
  pMD2.G   3.75 µg 
  pCMVΔR8.2   11.25 µg 
  PEI    120 µl 
 4. The mixture was vortexed for 10 sec, incubated for 10 min at RT and 
afterwards the DNA/PEI mixture was added drop-wise to the cells 
 5. Cells were incubated for 4-6 hours at 37°C 
 6. Afterwards the medium was replaced with 30 ml of DMEM/10% FCS 
II. Virus collection  
7. After 48 to 72h the supernatant was collected into 50 ml tube 
 8. The supernatant was spun down for 15 min at 3000 g 
 9. The supernatant was transferred into new special centrifuge tube  
 10. Virus particles were pelleted for 2 h at 75.000 g at 4°C 
 11. The pellet was marked and the supernatant was discarded 
 12. The pellet was dissolved in 150 µl DMEM/10% FCS by gentle 
pipetting 
IV. Materials and Methods 
58 
 
 13. The tubes were left on ice at 4°C overnight 
 14. Next morning the virus was carefully pipetted up and down a few 
times and frozen in small aliquots (a 30-50 µl) at -80°C 
III. Transduction of target cells 
 15. The day before transduction, target cells were plated to be around 50-
60% confluent on the day of transduction 
 16. Next morning the old media was replaced with 20 ml of DMEM/10% 
FCS 
 17. 20 µl Polybrene (8 mg/ml) and 50 µl of the virus were simultaneously 
drop-wise pipetted to the plate  
 18. 4-6 h after the medium was replaced with the new ones DMEM/10% 
FCS still w/o selection antibiotics 
 19. Next day the medium was replaced again and selection antibiotics 
were added. The medium was replaced every 3-4 days till the colonies grew 
 20. The colonies were picked and verified for an expected phenotype via 
Western Blot or immunofluorescence 
 
4. 5 Cell proliferation and invasion assays 
 4.5.1 MTT cell proliferation assay 
 This colorimetric assay is based on the ability of mitochondrial enzyme 
succinate dehydrogenase to reduce the yellow 3-(4,5-dimethythiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) to colored (dark purple) formazan. When 
MTT enters the cells and passes into the mitochondria, the above-mentioned 
reaction proceeds. The cells are then solubilized with an organic solvent and the 
released formazan is measured spectrophotometrically. Since MTT is reduced 
only by live cells, the level of activity is a measure of the cell viability and 
proliferation. 
 Reagents 
 MTT (5 mg/ml in PBS)  
 Dimethyl sulfoxide  
 Procedure 
1. The cells were seeded 50000 cell/well in 12 well plate in triplicates for 6 days 
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2. One well for a blank w/o cells was prepared by putting only medium inside  
2. 24 h after the medium was removed from the plate for the first day and 500 μl 
of the new medium were added to each well (including blank well) 
3. 100 μl of MTT were added per well, including blank well and incubated for 30 
min at 37°C 
4. The supernatant was removed from the plate, 500 μl DMSO were added per 
well and shacked for 10 min on a shaker 
5. The cuvettes for each sample in triplicates and for a blank were prepared 
6. 900 μl H2O were added into each cuvette 
7. 100 μl from each well were pipetted to the cuvettes in triplicates and mixed 
9. The procedure was repeated on the day 2 to 6. The extinction was measured 
at 570 nm in a photometer. Cell proliferation was then calculated through on all 
days in comparison to the control sample  
 4.5.2 Transwell cell migration assay 
 The transwell migration assay known also as the Boyden or modified 
Boyden chamber assay is a widely distributed method to investigate the 
migratory response of cells investigated. Boyden chamber represents a 
cylindrical cell insert with a semipermeable polycarbonate membrane with 
defined pore size. Cells are placed in the top of the insert in serum-free media, 
while serum-containing media is covering the well below. The cells are then 
moving through the pores towards the FCS (chemoattractant) below. Afterwards 
migratory cells are stained and their number is determined.  
 Reagents 
 DMEM w/o FCS 
 DMEM + 20 % FCS  
 Paraformaldehyde 3.7 % in PBS  
 DAPI 1 mg/ml 
 Methanol ice cold  
 Procedure 
1. The migration chambers were put into 24-well plate  
2. 100 µL serum-free medium were added in the chamber 
3. 200 µL of the cell suspension were placed in the chamber (2.5*105/mL in 
serum-free medium) 
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4. 750 µL of the culture medium (with serum) were added in lower chamber 
5. Migration chamber was put into the lower well 
6. The samples were incubated at 37°C for 12-16 hours  
7. Afterwards the medium was removed  
8. The migration chamber was washed twice with PBS  
9. The cells were fixed by paraformaldehyde for 2 min at RT  
10. The migration chamber was washed twice with PBS 
11. The cells were permeabilized by 100 % methanol for 10 min at RT 
12. Methanol was removed and the chamber was washed twice with PBS 
13. The cells were stained with DAPI (1:1000 in PBTw) at RT for 15 min  
14. The stain was removed and the chamber was washed twice with PBS 
15. Non-migrated cells were scraped off with cotton swabs 
16. Migrated cells were counted under microscope 
 4.5.3 Scratch/wound healing assay 
 An additional method to describe the cell migration pattern is 
scratch/wound healing assay. During this test, the cells were grown to a 
confluence and the “wound” was then created by scratching in the middle of the 
monolayer with a pipette tip. Immediately after, the picture of the “wound” was 
taken, determining a zero time point. The “healing” of the gap by cell migration 
towards the center of the gap was observed and documented at the defined time 
points. Another opportunity to create the “wound” is the use of special cell inserts 
(culture-insert 2 well, Ibidi) according to the manufacturer instructions. 
 4.5.4 Soft Agar Colony Formation Assay  
 One of the most notable hallmarks of carcinogenesis is the ability of 
cancer cells to grow without attaching to a solid surface. Soft agar colony 
formation assay shows whether investigated cells are able to grow in semi-solid 
matrices and provides an ideal tool to examine cell transformation in vitro. 
Additionally, this assay enables to observe probable changes in a cell behavior 
comparing the control and genetically modified cell lines.  
 Reagents 
 1 % agarose and 0.6 % agarose in H2Odd 
 2xDMEM with 20 % FCS and 2 % Penicillin/Streptomycin  
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 0.1 % Crystal Violet in 10 % EtOH   
 Procedure 
I. Preparation of Base Agarose 
1. 1 % agarose and 0.6 % agarose were prepare in H2Odd and autoclaved 
2. 1 % agarose was melted in a microwave and cooled down to 40 °C in a water 
bath 
3. 2x DMEM with 20 % FCS and 2 % P/S was prepared and prewarmed to 40 °C 
in a water bath 
4. 6 ml of 2x DMEM were mixed with 6 ml 1 % agarose and added 1.5 ml/well in 
a 6-well plate  
5. The plates were at RT for 10-30 min to solidify 
II. Preparation of Top Agarose 
1. Cell samples were prepared by trypsinizing cells and counting them. An 
aliquot of each sample with a concentration of 1x104 cells/ml was made. Each 
aliquot was kept at 37 °C for 10-20 min 
2. 0.6 % agarose was melted in a microwave and cooled down to 40 °C in a 
water bath 
3. 3 ml of cell suspension in 2x DMEM were mixed with 3 ml 0.6 % agarose. 1 ml 
of the mixture was pipetted into the well and allowed 15 minutes to solidify 
4. 1 mL 1x full media was added to each well 
5. Plates were incubated at 37 °C in humidified incubator for 28 days 
6. Cells were fed once - twice per week 
III. Staining 
1. The cells were stained with 0.5 mL 0.1% Crystal Violet in 10% EtOH for 10 
min  
2. Crystal violet was washed off by adding 1‐2 mL water to soft agar 4‐5 times   
3. Colonies were imaged on a dissecting microscope and counted 
4.6 Western Blot 
4.6.1 Western Blot and SDS-PAGE sample preparation 
 Polyacrylamide gel electrophoresis (PAGE) is one of the most common 
analytical techniques used to separate proteins. Proteins can be separated on 
polyacrylamide gels on the basis of their electrophoretic mobility. To separate the 
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band(s) of interest, different polyacrylamide gel concentrations are used.  To 
obtain optimal resolution of proteins, two gels are used: a ‘stacking’ gel is cast on 
the top of the ‘resolving’ gel. The stacking gel has a lower concentration of 
acrylamide, lower pH and a different ionic content. This allows the proteins in the 
samples to be concentrated into a tight band before entering the resolving gel.  
 Sodium dodecyl sulfate (SDS) is an amphipathic detergent and binds non-
covalently to proteins, prompting protein denaturation and disassociation from 
each other while conferring a negative charge. The addition of β-
mercaptoethanol-containing sample buffer disrupts disulfide bridges within 
polypeptides. Furthermore, secondary and tertiary structures are lost after 5 
minutes of protein-boiling.  
 Reagents 
 5x Loading buffer  
 Ammonium persulfate (APS) (10 %) 
 β-mercaptoethanol or DTT 1 M 
 TNT lysis buffer with protease inhibitors 
 Bradford solution 1:5 in H2Odd 
 Stacking gel buffer: Tris-HCl (1 M, pH 8.8) 
 Resolving gel buffer: Tris-HCl (1 M, pH 6.8) 
 Electrophoresis buffer (5x) (0.12 M Tris base, 0.96 M glycine, 0.5% 
SDS, pH 8.3) 
 Acrylamide/Bisacrylamide (30%)  
 TEMED 
 Prestained protein ladder  
Procedure 
1. The cells were grown in 10 cm dishes till 80% of confluence 
2. If required, the cells were starved overnight and FCS was added for 1 h  
3. 1 % β-mercaptoethanol or 200 μM DTT were added to the sample buffer 
4. The cells were detached with the help of a cell scraper and gathered into an 
Eppendorf tube 
5. The culture medium was discarded after centrifugation and 60-100 µl of TNT 
lysis buffer with supplements were added  
6. The cells had to lyse 20 min on ice 
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7. The samples were sonicated for 10 s  
8. The samples were spun down for 10 min at 15000 rpm 
9. The supernatant was transferred into a new tube 
10. 1 μl of the sample was measured with Bradford reagent and all samples were 
adjusted with TNT buffer to the same protein amount in 16 μl and 4 μl of 5x 
sample buffer were added 
11. The samples were boiled at 95 ˚C for 5 min to denature them 
12. The glass gel plates were rinsed with 70 % ethanol and placed in the gel 
holders 
13. The reagents for the four 10 % resolving gels were mixed according to Table 
22, pipetted between the glass plates, layered with isopropanol and left for 30 
min for polymerization 
Table 22 Polyacrylamide gel composition 
10% resolving gel 4% stacking gel 
Water 9.8 ml Water 7.2 ml 
1 M TrisHCl, 
pH 8.8 
14 ml 1 M TrisHCl,  
pH 6.8 
1.2 ml 
Acrylamide 
30% 
12.2 ml Acrylamide 30% 1.6 ml 
SDS 10% 350 µl SDS 10% 100 µl 
APS 10% 185 µl APS 10% 52 µl 
TEMED 30 µl TEMED 20 µl 
 
14. The water was removed and 4 % stacking gel was applied (see Table 22) to 
the top of the polymerized resolving gel 
15. The combs were placed in the gel and the gel was allowed to polymerize for 
30 min 
16. The glass plates containing the polymerized gel were removed and placed 
into the electrophoresis chamber 
17. The chamber was filled with 1x electrophoresis buffer 
18. 7 µl of molecular weight marker and 20 µl of the samples were pipetted into 
the gel slots 
15. The electrophoresis was conducted at 180 V for 90-120 min  
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 4.6.2 Western Blot  
 The first step in the Western blotting procedure is the separation of 
proteins using gel electrophoresis. Thereafter, the separated molecules are 
transferred onto a second matrix, a nitrocellulose membrane, utilizing electrical 
fields. Since the protein-bound SDS is washed out in this step, the proteins 
regain their original primary, secondary, and tertiary structure to some extent. 
Next, the membrane is blocked with protein solutions containing bovine serum 
albumin or fat-free milk powder to prevent any nonspecific binding of antibodies 
to the surface of the membrane. Thereafter primary and secondary antibodies 
are added one by one. Primary antibody binds the target protein, whereas the 
secondary antibody, conjugated to the enzyme horseradish peroxidase, allows 
the detection. Horseradish peroxidase converts substrate (Advansta solution) 
into its oxidized form, which then can be detected in chemiluminescence 
analyzer. 
 Reagents 
 Transfer buffer 
 Ponceau S solution 
 Tris-buffered saline (TBS) -buffer (20x):  
 TBS/T buffer (1x): TBS, 0.1% Tween 20 
 Blocking buffer 
 Primary antibody in blocking buffer at desired concentration (see 
Table 4) 
 Secondary antibody in blocking buffer (see Table 5)  
 Detection solution 
Procedure 
1. The filter paper and nitrocellulose membrane were adjusted to match the gel 
size 
2. The membrane, gel blotting paper, and sponges were moistened in transfer 
buffer 
3. Gel blotting paper, nitrocellulose membrane, gel and sponges were taken 
together to form a blotting sandwich 
4.  The blotting sandwich was placed in the blot module with the gel facing the 
cathode side, and the membrane facing the anode side 
IV. Materials and Methods 
65 
 
5. The module was filled up with transfer buffer  
6. The blotting process was performed for 80 min at 100 V 
7. The membrane was placed in a Ponceau S solution to check the proper 
blotting and to visualize the blotted proteins 
8. The membrane was washed with distilled water 
9. The rests of the Ponceau S solution were washed away from the membrane in 
TBS/T buffer and then rinsed with distilled water 
10. The membrane was incubated in 10 ml blocking buffer for 1 h at room 
temperature  
11. The membrane was incubated with the primary antibody at 4 °C overnight 
12. The membrane was washed 3x 5 min each with TBS/T buffer 
13. The membrane was incubated with the secondary antibody for 1 h at room 
temperature 
14. The membrane was washed 3x 5 min each with TBS/T buffer 
15. The membrane was covered with the detection solution for 1 min and the 
chemiluminescence was detected by Fusion FX7 imager 
4.7 Immunofluorescence 
 Immunofluorescence is a widely applicable method and allows 
researchers to visualize the localization, structure or intracellular behavior of 
antigen directly in a cell or in a tissue section. In this assay, target molecules are 
captured by the specific primary antibody, which in its turn is able to bind the 
secondary antibody conjugated to a fluorophore. This fluorophore generates 
photons and emits light, thus allowing microscope detection of the protein of 
interest. Use of several fluorophores enables simultaneous detection of multiple 
proteins and is helpful to gain the knowledge about proteins interaction and their 
co-localization.   
 Reagents 
 1x PBS pH 7.4 
 1x PBTw (0.1 % Tween in PBS) 
 1x PBTw + 5 % BSA 
 Mowiol 
 Methanol 100 % 
 PFA 4 % in 1x PBS 
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 DAPI 1 mg/ml 
 Procedure 
1. The cells were grown on glass coverslips in a 6-well plate 
2. The medium was discarded and coverslips were washed with PBS 
3. The coverslips were covered either with 4 % PFA in PBS for 20 min at RT 
or with ice-cold methanol and for 20 min at -20 °C 
4. The coverslips were washed three times with PBTw, 10 min each 
5. The coverslips were blocked for 30 min - 1 hour in PBTw 5 % BSA 
6. The first antibody was incubated in an appropriate dilution overnight in 
PBTw 5% BSA, covered against light, at 4°  
7. The coverslips were shortly washed three times with PBTw 
8. The secondary antibodies were incubated in PBTw 5 % BSA 1-2 hours, 
covered against light, at RT  
9. The coverslips were shortly washed three times with PBTw  
10. The coverslips were stained with DAPI (1:1000 in PBTw) at RT for 15 
minutes  
11. The coverslips were shortly washed three times with PBTw 
12. Glass slides with a drop Mowiol on it were prepare  
13. The coverslips were placed on the glass slides upside down 
14. The glass slides were dried at 37° for at least 1h 
15. The IFs were visualized using fluorescence microscope  
4.8 Real-time PCR 
 4.8.1 RNA-isolation 
 To analyze the genes transcribed, RNA isolation and purification was 
carried out with the help of Trizol (TRI Reagent Solution) reagent. This method 
can be used not only for RNA isolation but for protein and DNA-isolation as well, 
as these three compounds are separated in three different phases. After 
centrifugation, the mixture separates into a lower red phenol-chloroform phase, a 
white interphase and a colorless upper aqueous phase. RNA is found entirely in 
the aqueous phase. To prevent the degradation of RNA by RNases, the Trizol 
reagent contains phenol and guanidine-thiocyanate.  
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 Reagents 
 Trizol (TRI Reagent Solution) 
 Chloroform 
 Isopropanol 100% 
 75% EtOH in diethylpyrocarbonate water 
 RNAse free water 
 Procedure 
1. The cells were seeded in 6-well plates, starved overnight, fed in the 
morning with 20 % FCS for 2 hours and lysed by adding 1 ml Trizol to each 
sample 
2. 200 µl chloroform were added to each sample 
3. The samples were mixed for 15 sec and kept at room temperature for 2-3 
min 
4. The samples were spun down at 4 ºC  for 15 min at 12 000 g 
5. The top aqueous phase was transferred to a new Eppendorf tube and 
500 µl of isopropyl alcohol were added to each sample 
6. The samples were mixed briefly and left for 10 min at room temperature 
7. The samples were spun down at 4 ºC  for 10 min at 12 000 g 
8. The supernatant was discarded and 1 ml of 75 % ethanol was added to 
the pellet 
9. The samples were vortexed and centrifuged at 4 ºC  for 5 min at 7 500 g 
10.  The supernatant was removed and the pellet was air-dried for 10 min 
11.  The pellet was resuspended in 15 µl RNAse free water  
12.  The samples were frozen for 15 min or overnight at -80 ºC 
13. The RNA concentration was measured at Nanodrop 
4.8.2 Reverse transcription 
For reverse transcription of isolated RNA into cDNA (complementary 
DNA) the qScript cDNA Synthesis Kit (Quanta Biosciences) was used. This kit 
provides oligo-dT primer (complementary to the poly-A-tail at the 3’end of the 
mRNA) and random hexamer primers. Primer annealing to mRNA results in 
double-stranded DNA/RNA molecules serving as a starting point for DNA 
synthesis by reverse transcriptase enzymes. 
  
IV. Materials and Methods 
68 
 
 Reagents 
 RNase-Free Distilled Water  
 5x qScript Reaction Mix (qScript cDNA Synthesis Kit) 
 Reverse Transcriptase (qScript cDNA Synthesis Kit) 
 Procedure 
1. RNase-Free distilled water, the 5x mix and reverse transcriptase were 
mixed in an Eppendorf tube 
2. The calculated amounts of the RNA-sample (1 µg) and RNase-Free 
distilled water were added to 15 µl of the mixture. The total volume 
constituted 20 µl 
3. The samples were incubated for 5 min at 25 ºC 
4. The samples were incubated for 45 min at 42 ºC 
5. The samples were incubated for 5 min at 85 ºC 
6. The PCR samples were stored at -20 ºC 
4.8.3 Real-time PCR 
Real-time quantitative PCR provides sensitive, specific and reproducible 
quantitation of nucleic acids. Real-time PCR enables reliable detection and 
measurement of products obtained during each cycle of the PCR process. The 
DNA amount is measured after each cycle by the use of fluorescent markers that 
are incorporated into the PCR product. In the exponential phase of the reaction, 
the increase in fluorescent signal is directly proportional to the number of PCR 
product molecules generated. One of the commonly used fluorescent DNA-
binding dyes is SYBR Green. It binds all double–stranded DNA and the increase 
in fluorescence is detected. SYBR Green has excitation and emission maxima of 
494 nm and 521 nm, respectively.  
To observe the ’purity’ of the obtained product, check the primer-dimer 
artifacts and contamination, post-amplification melting curve analysis is 
performed. To get the melting curves the PCR product is exposed to a 
temperature gradient. While heating, the dsDNA dissociates and SYBRGreen is 
released, resulting in a decrease in fluorescence. Thereafter the change of 
fluorescence with time is plotted against temperature.  Contaminating DNA or 
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primer dimers would appear as an additional peak separated from the desired 
peak. 
For quantification, the detected fluorescence is plotted against the number 
of PCR cycles, which shows the amplification of the PCR-product in time. As the 
equivalent of the amount of DNA in each sample, the Ct (threshold cycle) value 
is determined. The Ct defines the number of cycles required for the fluorescent 
signal to cross the specified threshold for being detectable. The lower the Ct 
level the greater the amount of target nucleic acid in the sample, thus Ct levels 
are inversely proportional to the amount of target nucleic acid in the sample. The 
Ct of each sample is chosen to be in the exponential phase of the amplification 
curve.  
To determine the concentration of DNA relative to the housekeeping gene 
GAPDH or Lamin A/C, whose expression remains constant under a wide variety 
of physiological conditions, the ΔΔCt method is used. ΔΔCt is obtained by 
deducting the ΔCt value of the reference sample (i.e. control sample) from the 
ΔCt value of the target sample. ΔCt value is determined by subtracting the Ct 
value of the sample and Ct value of the housekeeping gene. The relative 
expression difference between sample and control or reference sample 
normalized to a housekeeping gene is calculated by using the formula:  
Relative expression difference = 2-ΔΔCt 
In this thesis, real-time PCR was applied for mRNA expression analysis.  
Reagents 
 SensiFAST SYBR® No-ROX Kit - SYBR Green QPCR Master Mix 
 Primers dissolved in H2Odd 
 cDNA 25 ng/µl 
Procedure 
1. Separate master mixes were prepared for each sample (the gene of 
interest and the housekeeping gene) in sterile 1.5 ml reaction tubes on 
ice as summarized in the Table 23. 
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         Table 23 Reagents per each cDNA/DNA sample for real-time PCR 
Reagent Volume (µl) 
H2Odd 4.4 
SYBR Green QPCR Master Mix 10 
Primers sense + antisense (10 µM) 1.6 
Template 4 
 
2. 4 µl of cDNA were added to 16 μl master mix and pipetted into a 96-well 
PCR plate in triplicates 
3. For each primer pair a real-time PCR standard curve slope showing 
primer efficacy was pipetted in triplicates as well (100 ng/µl, 50 ng/µl, 25 
ng/µl template) 
4. Amplification was performed as shown in the Table 24. 
  Table 24 PCR program 
Temperature Duration Cycles 
95  ºC 7 min 1x 
95  ºC 20 sec 
40x 60  ºC 10 sec 
72  ºC 10 sec 
20  ºC ∞  
Melting curve 
Temperature Duration Cycles 
95 ºC 5 sec 1x 
40 ºC 1 min 1x 
97 ºC ∞  
4.9 Animal treatment and xenotransplantation 
 Male and female newborn NOD Scid Gamma (NSG) mice were kindly 
provided by Dr. Anja-Kathrin Wege (Institute for Experimental Immunology, 
University of Regensburg) and maintained in the pathogen-free animal facilities 
of the University Hospital Regensburg. An NSG mouse is the best model for 
engraftment of human cancer cells, as it combines the features of the 
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NOD/ShiLtJ background, the severe combined immune deficiency mutation 
(scid) and IL2 receptor gamma chain. As a result of these mutations this mouse 
is highly immunodeficient, lacking mature T, B and NK cells and showing an 
absence of functional complement system.  
 The mice of 2-3 days age were irradiated and injected subcutaneously 
with 20 000 cells with a syringe under the right front paw. Tumor growth was 
monitored twice a week and tumor size was measured. After 5 weeks the mice 
were sacrificed and lungs, liver and brain were taken for further 
immunohistochemistry (IHC), kindly performed by Rudolf Jung and Florian 
Weber (Institute of Pathology, University Hospital Regensburg). 
4.10 Statistical analysis 
The results obtained from a series of experiments (number of experiments 
is shown as n = x) are expressed as mean values together with the standard 
deviation (SD) or standard error of the mean (SEM). The statistical significance 
was calculated using GraphPad Prism (GraphPad software, La Jolla, CA, USA). 
Statistical significances calculated by Student’s or ANOVA/Dunnett’s post hoc 
test are represented as follows: *p< 0.05, **p< 0.01 and ***p< 0.001. Multiple 
comparisons involved ANOVA calculation with Tukey’s post-hoc-tests. The 
values lying below the detection range or such that they were not detected, were 
not taken into consideration in the statistical analysis. 
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V. Results 
5.1 Pals1 knockdown affects TJ formation  
 The Madin-Darby Canine Kidney (MDCK) cell line is one of the most 
widely used models to study cell polarity, as these cells are characterized by 
well-defined apicobasal polarity and well-formed tight junctions. This cell line also 
grows fast (Cho et al. 1989) and forms an obvious monolayer, making it well 
suited for molecular studies, as well as for immunofluorescence staining (Dukes 
et al. 2011). Since its establishment from canine kidney in 1966 (Gaush et al. 
1966), this cell line remains the most applicable model for epithelial cell polarity 
studies. There are several sub-types of a parental MDCK cell line, however, all 
experiments performed in this thesis utilized MDCK II sub-type. 
 To explore the role of Pals1 protein in vitro, several oligonucleotides 
(shRNA’s) were chosen to target Pals1 canine mRNA to promote long-term 
Pals1 knockdown. The chosen shRNA’s were cloned into a pSuperior.puro 
destination vector and subsequently transfected into MDCK II cells. Around two 
weeks after transfection and puromycine selection, distinct clones were picked 
and screened via Western Blot to determine the level of Pals1 suppression. Two 
stable cell lines showing Pals1 knockdown via two different shRNA’s were 
obtained.  
 
 
 
 
 
 
 
Figure 5.1.1: Stable Pals1 knockdown cell lines, showing a reduction of Pals1 protein 
levels in MDCK cells   
Cell lysates of determined cell lines were prepared and subjected to Western Blot using anti-
Pals1 antibody. Representative Western Blot is shown together with actin blot to verify equal 
loading. Relative molecular mass is presented to the right in kilodaltons (kD). 
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 To exclude possible off-target effects, a scrambled (Scrbld) nonsense 
shRNA was cloned into a pSuperior.puro vector and introduced into MDCK 
wildtype cells (wt) to act as a negative control in all further experiments. Figure 
5.1.1 represents the reduction of Pals1 expression by 70-80 % in MDCK with 
Pals1 sh1 and MDCK Pals1 sh2, whereas Pals1 expression in MDCK Scrbld 
remains unaffected. By using a Western Blot, Pals1 is determined by two specific 
bands near to each other, probably defining two MPP5 splicing variants. 
 It is worth noting that the first visible observation of MDCK Pals1-KD cell 
lines under a microscope revealed a clear morphological transition. Cells lacking 
Pals1 switched their polygonal epithelial phenotype to a spindle-like 
mesenchymal cell morphology (Figure 5.1.2), whereas MDCK Scrbld cells 
remained relatively unchanged. 
 
Figure 5.1.2: Light field microscopy of MDCK Pals1 knockdown cell lines 
Cells were grown in Petri dishes to nicely formed islets. For imaging, the growth medium was 
removed, cells were washed once with PBS and covered with 5 ml new PBS. Brightfield pictures 
were obtained on an inverted microscope. The scale bars = 100 μm.  
 
 Interestingly, not only cell shape changes were observed. It is clearly seen 
that Pals1 knockdown is associated with an increase in cell size, especially 
comparing MDCK Pals1 sh1 and MDCK wt. MDCK Pals1 sh2 in contrast to 
MDCK wt also seems to cause an excess cell growth, although to a lesser 
extent. However, MDCK Scrbld cells are slightly enlarged as well, indicating 
probable side-effects of the transfection procedure and unpredicted genome 
integrations.     
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 To find out, whether Pals1 knockdown influences tight junction formation 
and the integrity of cell-cell contacts, the cells were stained for the tight junction 
marker ZO-1, and AJ protein E-cadherin, as it plays a key role at adherens 
junctions between epithelial cells. Co-staining with Pals1 confirmed the Pals1 
reduction obtained in Pals1 knockdown cell lines. 
  
Figure 5.1.3: Immunostaining of stable MDCK Pals1 knockdown cell lines 
Cells were grown on coverslips to confluence, fixed in methanol and stained for Pals1, ZO-1 and 
E-cadherin. Secondary antibodies coupled to fluorochromes enabled visualization. Merged 
images between the individual channels with DAPI nuclear counterstains are shown on the right. 
All images were acquired using similar settings on the laser-scanning microscope. The scale 
bars = 20 μm. 
  
 Moreover, MDCK Pals1-KD cell lines showed a slight decrease in ZO-1 
expression and partial TJ structure disruption in contrast to MDCK Scrbld (Figure 
5.1.3). Interestingly, although E-cadherin shows the expected localization pattern 
at lateral cell-cell junctions, the expression levels in MDCK Pals1-KD cell lines 
seem to be partially reduced and internalized. 
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 Next, it was of interest to examine the role of Pals1 in the formation of 
cell-cell contacts and TJ dynamics. In order to answer this question, a calcium 
switch assay was performed.  
 
Figure 5.1.4: Calcium switch assay in stable MDCK Pals1 knockdown cell lines 
Cells were grown on coverslips to confluence, placed overnight to calcium-low medium, then 
transferred back to the normal growth medium. At 0h, 1h, 4h and 24h after recovery cells were 
fixed in methanol and stained for ZO-1 and E-cadherin. Secondary antibodies coupled to 
fluorochromes enabled visualization. Merged images between the individual channels with DAPI 
nuclear counterstains are shown. All images were acquired using similar settings on the laser-
scanning microscope. The scale bars = 20 μm. 
 
 Cells were cultured on coverslips to confluence, placed into medium 
without Ca2+ and only with 5% dialyzed FCS and incubated for 16 h at 37°C to 
break cell-cell contacts. Next morning the cells were placed back to the normal 
growth medium and TJ formation de novo was observed. For this reason, the 
cells were fixed at different time points and immunostained for E-cadherin and 
ZO-1 to observe tight junction and cell-cell contact rehabilitation (Figure 5.1.4).   
 As it is clearly seen at zero time point after calcium starvation, both MDCK 
Scrbld and MDCK Pals1-KD cell lines showed similar, almost complete 
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dissolution of cell-cell contacts. However, after placing to the normal growth 
medium, MDCK Scrbld reformed TJ faster, recruiting up to 90% of ZO-1 protein 
to TJ within 4 hours. In comparison, even after 24 hours, the MDCK Pals1-KD 
cell line was still unable to complete reassembly of cell-cell contacts. Thus, Pals1 
knockdown cell line showed a dramatic delay in tight junction formation in 
comparison to the control cells. Additionally, in MDCK Scrbld cells E-cadherin 
was fully recruited back and formed adherens junctions within 24 hours, whereas 
MDCK Pals1-KD showed only slight differences in E-cadherin localization during 
all time points observed, indicating E-cadherin internalization and cell-cell 
contact weakening under Pals1 knockdown in MDCK cells.    
5.2 Loss of Pals1 results in altered expression of polarity 
proteins 
 Regulation of apicobasal polarity relies on a complex interplay between 
evolutionarily conserved groups of polarity proteins. To characterize the impact 
of Pals1 knockdown on epithelial cell polarity maintenance and investigate the 
role of Pals1 in polarity establishment, Western Blot was carried out on MDCK 
Pals1-KD cell lines to determine the expression levels of other polarity proteins. 
It was of interest to analyze the members of Par complex, especially the Par6 
protein, as Pals1 interacts directly with Par6. However, in mammals, distinct 
Par6 isoforms (Par6α, Par6β and Par6γ) were shown to exhibit different 
functions and divergent Pals1 binding capacity. For instance, Par6α and Pals1 
interactions are much weaker in a comparison to Par6β and Par6γ, even in the 
presence of active Cdc42 (Gao, Macara 2004). Thus, the levels of Cdc42 were 
verified as well. In addition, with the observation that loss of Pals1 in MDCK cells 
results in mesenchymal-like cell morphology and adherens junction disruption, 
the level of E-cadherin as well as the expression rates of EMT markers αSMA 
and Vimentin were determined (Figure 5.2.1). To ensure that the band density 
was not influenced by different protein amounts, β-actin was used as a loading 
control.  
 Immunoblotting showed that cells with Pals1 knockdown displayed a 
marked increase in aPKC and Cdc42 levels. Moreover, loss of Pals1 had a 
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distinct impact on Par6 isoforms, demonstrating enhanced Par6α expression, no 
changes in Par6β and a significant decrease in Par6γ levels.  
 In contrast to the scrambled control, reduced E-cadherin expression in 
both MDCK Pals1-KD cell lines with a simultaneous increase in αSMA and 
Vimentin amounts might be inherent to EMT. So, reduced Pals1 levels result in 
altered polarity protein expression pattern and might be one of the reasons for 
epithelial-to-mesenchymal transition. 
 
 
Figure 5.2.1: Western Blot analysis of stable MDCK Pals1 knockdown cell lines 
Cells were grown in 10 cm plates to confluence, scraped and lysed in TNT lysis buffer with 
subsequent sonication.  Protein quantification was performed by Bradford method. Afterwards, 
each sample was adjusted to 30 µg of the whole cell lysate and differential protein expression 
levels were determined by immunoblotting. β – actin was used as a loading control. 
Representative Western Blots are shown (left) and quantifications (right) are then given as 
means + SEM from n = 3 independent experiments. 
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5.3 Lack of Pals1 expression leads to enhanced cell 
motility  
 Combining the data obtained by Western Blot and immunofluorescence 
analysis of MDCK Pals1-KD cell lines, it seems plausible that Pals1 might be 
related to EMT. Hence, it was of interest to evaluate the possible contribution of 
Pals1 to cell migration. For this reason, scratch/wound healing and transwell 
migration assays were performed. To quantify cell motility out from the 
scratch/wound healing assay, cells were seeded in 6-well plates and grown to 
confluence. Next, the cell monolayer was disrupted mechanically creating a 
“wound” with a pipette tip. To evaluate cell migration in vitro, images 
representing “wound” closure at different time points, were taken.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.1: Scratch/wound healing (A) and transwell migration (B) assays of stable 
MDCK Pals1 knockdown cell lines 
A. Confluent monolayer of cells was scratched with a tip to mimic the wound. Pictures, illustrating 
the healing, were taken at 0 h (immediately after scratch) and 18 h. One representative assay of 
n=3 independent experiments is shown. B. Cells were seeded in the FCS-free medium on 
transwell inserts. Cell migration towards FCS was evaluated by a number of cells, passed 
through the semipermeable membrane. Data are shown as means + SEM from n = 3 
independent experiments. Statistically significant differences between MDCK Scrbld and MDCK 
Pals1 sh1/MDCK Pals1 sh2 respectively are indicated: *p<0.05, **p<0.01, Student's t-test. 
B A 
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 As shown in Figure 5.3.1 A, cells with Pals1 knockdown close the gap and 
recover the monolayer significantly faster than the control group. Markedly 
enhanced cell motility was also confirmed performing cell transwell migration 
assay (Figure 5.3.1 B).  Cells lacking Pals1 migrated up to 50% more compared 
to the control cell line. These results suggest that downregulation of Pals1 
drastically enhances the migration capacity of MDCK cells. 
5.4 Pals1 downregulation leads to overexpression of EMT 
markers and affects Hippo signaling pathway  
 The Hippo pathway controls cell proliferation and tissue growth while 
sensing cell density and mediating YAP cytoplasmic or nuclear localization. 
Transcriptionally active YAP promotes gene expression, whereas the 
phosphorylated form of YAP is not able to translocate into the nucleus and 
sequesters in the cytoplasm. According to Varelas et al., in immunoprecipitation 
studies Pals1 was shown to interact directly with YAP thus linking cellular 
proliferative activity to epithelial polarity (Varelas et al. 2010). Therefore, in the 
next step, it was of interest to assess the feasible impact of Pals1 loss on the 
Hippo pathway. Western Blot analysis of MDCK Pals1-KD cell lines revealed a 
significant drop in YAP phosphorylation with Pals1 knockdown, whereas YAP 
levels remained unaffected (Figure 5.4.1). The immunofluorescent analysis 
confirmed deregulation in Hippo signaling under Pals1 knockdown. In contrast to 
the control MDCK Scrbld cell line, where YAP localizes to the TJ, loss of Pals1 
stimulates translocation of YAP into the nucleus (Figure 5.4.2). 
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Figure 5.4.1: Western Blot analysis of stable MDCK Pals1 knockdown cell lines against 
transcriptional regulator YAP 
Cells were grown in 10 cm plates, starved overnight in DMEM w/o FCS. After 16 h Hippo 
pathway was reactivated by FCS addition for 1 h. Afterward, cells were lysed in Laemli buffer and 
applied to Western Blot against YAP and pYAP. β-actin was used as loading control. 
Representative Western Blots are shown (left) and quantifications (right) are then given as 
means + SEM from n = 3 independent experiments. Band intensities were quantified by 
densitometry and are indicated as pYAP/YAP expression relative to that of β-actin. Statistically 
significant differences are indicated (*p < 0.05, ANOVA/Dunnett's post hoc test). 
Figure 5.4.2: Immunofluorescent analysis of stable MDCK Pals1 sh1 knockdown cell 
line against transcriptional regulator YAP 
Cells were grown in 6-well plates on coverslips. Upon pre-confluency cells were starved 
overnight in DMEM w/o FCS. After 16 h the Hippo pathway was reactivated by FCS addition for 
1 h. Afterward, cells were fixed in immunostained against YAP and counterstained with DAPI. 
The scale bars = 20 μm.  
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To elucidate whether nuclear sequestration of YAP in MDCK Pals1-KD cells 
promotes further transcriptional activation, RT-PCR for Hippo downstream 
targets was performed. Figure 5.4.3 represents the analysis of CTGF, Pai-1 and 
Cyr61 mRNA. In addition, to validate epithelial to mesenchymal transition under 
Pals1 depletion, expression levels of EMT markers Snail and ZEB1 were 
investigated.        
 
 
 
 
 
 
 
 
 
Figure 5.4.3: Relative mRNA expression of CTGF, Cyr61, Pai-1, ZEB1 and Snail in MDCK 
Pals1-KD cell lines in contrast to the control cell line 
MDCK Scrbld, MDCK dogPals1 sh1 and MDCK dogPals1 sh2 cells were seeded in 12-well 
plates. The whole mRNA of each sample was extracted and after cDNA synthesis, real-time PCR 
was performed to quantify expression of defined genes. The fold of gene expression is defined 
as the fold of control of relative signal as compared to control cell line. GAPDH was used as a 
housekeeping gene control. The bars represent the means + SD from n = 3 independent 
experiments. Asterisks indicate statistically significant differences between groups (ANOVA/ 
Dunnett post hoc test, ***p < 0.001). 
 
 As can be seen in Figure 5.4.3, expression levels of three investigated 
YAP-downstream targets CTGF, Cyr 61 and Pai-1 are strongly increased in both 
Pals1-depleted cell lines in contrast to the MDCK Scrbld. Interestingly, Pai1 is 
also known to be TGF-β target gene, suggesting a further link between Pals1, 
the Hippo pathway and TGF-β–mediated signaling. Moreover, there are 
significant differences determined when comparing expression levels of Snail 
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and ZEB1. Elevated levels of this both master regulators indicate EMT switch in 
MDCK Pals1-KD cells. 
5.5 Pals1 knockdown affects cell polarity in HCT116 colon 
cancer cell line 
 One of the most abundant cancers diagnosed across the world each year 
is colorectal cancer. Colon cancer is in the top three main causes of cancer-
associated mortality (Arnold et al. 2016). To elucidate whether Pals1 is an 
important player in this disease, the histopathological examination of Pals1 in 
tissues from colon cancer patients was performed by Ludwig Lagleder. The 
obtained data appears to suggest that Pals1 decline correlates with colorectal 
tumor progression in patients. Thus, to deepen understanding of the role of 
Pals1 in colon cancer, two different cell lines with Pals1 knockdown in HCT116 
colon cancer cell line were created using an shRNA approach. At the same time, 
HCT116 cells were transfected with a pSuperior vector containing Scrambled 
shRNA as a control. All HCT116 cells, transfected with pSuperior hPals1 sh1, 
pSuperior hPals1 sh2 or pSuperior Scrambled were selected for 2 weeks with 
0.5 μg/ml puromycin until single cell colonies were formed.  Each clone was then 
blotted against Pals1 and Actin to verify Pals1 decline under shRNA. The clones 
showing the most significant reduction of Pals1 expression were chosen for 
further studies (Figure 5.5.1 A).  
Figure 5.5.1: Stable Pals1 knockdown (A), knockout and rescue (B) cell lines, showing 
reduction, absence and recovery respectively of Pals1 protein levels in HCT116 cells 
Cell lysates of determined cell lines were prepared and subjected to Western Blot using anti-
Pals1 antibody. Representative Western Blot is shown together with actin blot to verify equal 
loading. Relative molecular mass is presented to the right in kilodaltons. 
B A 
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 Moreover, as some of the human colon tissue samples showed as far as 
no Pals1 expression in cancer stage G3, it was of interest to explore the possible 
changes under complete Pals1 absence. Thus, using a CRISPR/Cas9 approach, 
an HCT116 cell line characterized by Pals1 knockout (KO) was created. To 
further verify that the changes upon Pals1 KO (ΔPals1) were directly due to the 
protein absence rather than off-target effects, the HCT116 ΔhPals1 cell line was 
rescued by the hPals1 expression construct (Figure 5.5.1 B). Whereas the 
introduction of the short hairpin RNAs sh1 and sh2 caused up to a 60%-80% 
reduction of endogenous Pals1 expression, Pals1 specific gRNA-guided 
CRISPR-Cas9 approach led to a complete Pals1 knockout, proved by 
immunoblot by the disappearance of the ~80 kDa bands representing Pals1. The 
introduction of nonsense shRNA had no influence on Pals1 expression (Figure 
5.5.1 A). The rescue mutant of HCT116 ΔhPals1 is characterized by the 
reappearance of the Pals1 band in Western Blot. These results indicated 
successful Pals1 gene knockdown, knockout and further rescue.  
 To assess the impact of Pals1 on cell polarity, the Hippo pathway and 
EMT in the colon cancer HCT116 cell line, immunoblot and RT-PCR were 
performed as previously done for MDCK cells. Pals1 knockdown, as well as 
Pals1 knockout, drastically influence the expression of several polarity proteins, 
causing a strong reduction of E-cadherin, Par6γ and Cdc42 levels. Intriguingly, 
aPKC expression pattern, together with Par6α and Par6β remain almost 
unaffected. HCT116 ΔhPals1 + Pals1 rescue mutant restores normal levels of 
Par6γ, Cdc42, E-cadherin and caused reverse MET, seen as an αSMA reduction 
compared to HCT116 ΔhPals1 (Figure 5.5.2 A and B). Contrary to our 
expectations, whereby HCT116 hPals1-KD cell lines similarly to MDCK 
dogPals1-KD indicate upregulation of Hippo signaling, there were no changes of 
pYAP/YAP levels observed, when comparing HCT116 wt and HCT116 ΔhPals1.   
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Figure 5.5.2: Western Blot analysis of stable HCT116 hPals1 knockdown (A) and 
knockout (B) cell lines 
Differential protein expression levels were determined by immunoblotting. β – actin was used as 
a loading control. Representative Western Blots are shown (left) and quantifications (right) are 
then given as means + SEM from n = 3 independent experiments. 
B 
A 
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 It is evident that Pals1 is highly important for EMT, as both Pals1-KD and 
KO result in E-cadherin expression decline and increased αSMA levels in 
HCT116 ΔhPals1. Further RT-PCR analysis of these cell lines supports our 
finding that the Hippo pathway is highly upregulated under Pals1-KD, showing a 
significant increase in the expression of Hippo signaling target genes CTGF, 
Birc2, and Cyr61, however unexpectedly less deregulated under Pals1 knockout 
(Figure 5.5.3 A and B).  
 
 
 
 
 
 
 
Figure 5.5.3: Relative mRNA expression of CTGF, Cyr61, Pai1, Birc2, ZEB1 and Snail in 
HCT116 hPals1-KD cell lines (A) and HCT116 ΔhPals1 cell line in contrast to the control 
HCT 116 wt, HCT116 Scrbld, HCT 116 hPals1 sh1, sh2 and HCT116 ΔhPals1 cells were seeded 
in 12-well plates. The whole mRNA of each sample was extracted and after cDNA synthesis, 
real-time PCR was performed to quantify expression of defined genes. The fold of gene 
expression is defined as the fold of control of relative signal as compared to HCT116 Scrbld (A) 
or HCT116 wt cell line (B). Lamin A/C was used as a housekeeping gene control. The bars 
represent the means + SEM from n = 3 independent experiments. Asterisks indicate statistically 
significant differences between groups (ANOVA/ Dunnett post hoc test, *p < 0.5, **p < 0.01, ***p 
< 0.001). 
 
 Whereas Snail levels under Pals1 decline did not change, a complete 
absence of Pals1 stimulates Snail overexpression and might promote 
subsequent EMT and enhanced motility. Induction of Twist indicates EMT 
progression as well. Interestingly, ZEB1 - another central EMT mediator seems 
to be enhanced only in HCT116 hPals1 sh2 cell line and even seems to be 
downregulated in HCT116 ΔhPals1.  
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 To assess whether the total absence of Pals1 expression also causes a 
similar phenotype in other epithelial cells, MDCK ΔdogPals1 and DLD1 ΔhPals1 
mutant cell lines were created using the CRISPR/Cas9 method and 
immunoblotted. Both knockout cell lines showed a slight downregulation of Par6γ 
and E-cadherin, and strong overexpression of αSMA (Figure 5.5.4). Similar to 
HCT116 ΔhPals1, total Pals1 absence does not appear to influence the Hippo 
pathway in MDCK and DLD1 cell lines. To find out the probable reason for the 
subtly different phenotypes under Pals1 knockout, the initial levels of Pals1 
protein were identified and compared among all investigated cell lines. For this 
purpose, MDCK wt, DLD1 wt and HCT116 wt together with their appropriate 
Pals1 knockout cell lines were lysed in TNT buffer, adjusted to 30 μg and 
subjected to Western Blot. 
 
 
 
 
 
 
 
Figure 5.5.4: Western Blot analysis of stable MDCK dogPals1 and DLD1 hPals1 
knockout cell lines 
Cells were grown in 10 cm plates to confluence, starved overnight in medium w/o FCS. 
Afterwards, 20% FCS was added for 1 h, cells were scraped and lysed in Laemli lysis buffer with 
subsequent sonication. Differential protein expression levels were determined by immunoblotting. 
β – actin was used as a loading control. Representative Western Blots are shown (left) and 
quantifications (right) are then given as means + SEM from n = 3 independent experiments. 
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It was possible to compare the samples as they were adjusted to the same 
protein content in the cell lysate, and blotted and developed simultaneously on 
one membrane. It is evident that among three cell lines compared, the MDCK 
cell line is characterized by the highest Pals1 expression level. Analyzing the 
remaining two cell lines, HCT116 appears to show the lowest initial Pals1 protein 
amount (Figure 5.5.5).  
 
 
 
 
 
 
 
Figure 5.5.5: Comparative Western Blot analysis of MDCK, DLD1 and HCT116 wild type 
and their derivative Pals1 knockout cell lines 
Cell lysates of determined cell lines were prepared and subjected to Western Blot using anti-
Pals1 antibody. Representative Western Blot of n=3 is shown together with actin blot to verify 
equal loading. Relative molecular mass is presented to the right in kilodaltons.  
5.6 Pals1-deficient cells show augmented cell proliferation  
 As described above, Pals1 may be an important regulator of the Hippo 
pathway. To check whether a reduction in Pals1 causes any impact on cell 
proliferation, MTT cell proliferation assays were carried out over one week for 
MDCK wt and MDCK ΔdogPals1 (Figure 5.6.1 A), HCT116 wt, HCT116 ΔhPals1 
and HCT116 ΔhPals1+ hPals1 (Figure 5.6.1 B), DLD1 wt and DLD1 ΔhPals1 
(Figure 5.6.1 C). Figure 5.6.1 shows elevated proliferation with MDCK and DLD1 
ΔPals1 compared to their corresponding wildtype cells. Moreover, contact 
inhibition by confluence slows down parental cell lines, while both knockout cell 
lines continue propagating. This might again indicate Hippo deregulation, as it is 
known that the Hippo pathway controls cell proliferation by contact inhibition 
(Gumbiner, Kim 2014). Indeed, there were no noticeable differences in cell 
proliferation observed in vitro, comparing HCT116 wt with both HCT116 ΔhPals1 
and HCT116 ΔhPals1+ hPals1 rescue mutant. 
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Figure 5.6.1: The effect of Pals1 knockout on the cell proliferation measured by the 
MTT test for MDCK (A), HCT116 (B) and DLD1 (C) cells. 
For each cell line, six 12-well plates with 50 000 cells a well were prepared. Cell metabolic 
activity was measured every 24 h over 6 days by the MTT reduction test. Dotted lines indicate 
time point of cell confluence. Data shown are means + SD from n=3 independent experiments.  
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5.7 Lack of Pals1 expression leads to enhanced cell 
motility in epithelial and colon cancer cell lines 
 To confirm epithelial to mesenchymal transition and the probable impact 
of Pals1 decline on cell motility, scratch/wound healing assays were carried out 
for HCT116 hPals1-KDs and KO compared to HCT116 Scrbld and wt, 
respectively. HCT116 Scrbld, HCT116 hPals1 sh1 and HCT116 hPals1 sh2 cells 
were cultured until confluency in 6-well plates. Using a pipette tip, a “wound” was 
created and healing was observed after 16 h. To determine the role of Pals1 
knockout in these cell lines, HCT116 wt, HCT 116 ΔhPals1 and HCT116 
ΔhPals1+hPals1 cells were seeded and grown until a monolayer was formed 
around the insert. Thereafter the inserts were taken out, leaving a precise 0.5 
mm open “wound”.  Cell motility was characterized by observing cell migration 
capacity at 0 h and 16 h (Figure 5.7.1).  
 Intriguingly, there were no differences in cell motility observed between 
the HCT116 Scrbld cell line and both HCT116 cell lines with reduced Pals1. After 
16 h, the wound closure under Pals1 knockdown was comparable to that of 
Scrbld. On the other hand, we can observe highly enhanced motility of cells 
completely lacking Pals1 in contrast to HCT116 wt. While HCT116 wt still did not 
manage to close the wound after 16 hours, HCT116 ΔhPals1 were markedly 
faster to close the gap and recover the monolayer. The restoration of Pals1 
expression in the HCT116 ΔhPals1 cell line slowed cell motility almost to the 
level of HCT116 wt, indicating that Pals1 plays an important role in EMT and cell 
motility.  
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Figure 5.7.1: Scratch/wound healing assays of stable HCT116 Pals1-KDs, KO and rescue 
mutant cell lines 
A confluent monolayer of cells was scratched with a tip to mimic the wound (for HCT116 Scrbld, 
HCT116 hPals sh1 and sh2), or the wound was created with Ibidi inserts (for HCT116 wt, 
HCT116 ΔhPals1+hPals1). Pictures, illustrating the healing, were taken at 0 h (immediately after 
scratch) and 16 h. One representative assay of n=3 independent experiments is shown. The 
scale bars = 200 μm. 
 
 Next, monolayer scratch assays were performed for MDCK and DLD1 cell 
lines, together with their derivative Pals1-KO cells respectively. To ensure that 
the observed wound closure was due to cell migration rather than cell 
proliferation, gap healing in MDCK was examined after 10 h. Comparing the 
migration capacity of MDCK and DLD1 cell lines with MDCK ΔdogPals1 and 
DLD1 ΔhPals1 cells, respectively, it is worth noting that Pals1 knockout 
drastically accelerates MDCK motility, but seems to have no significant impact 
on the DLD1 colon cancer cell line (Figure 5.7.2). Furthermore, both DLD1 wt 
and DLD1 ΔhPals1 did not manage to heal the wound even after 48h, 
suggesting a general migration inadequacy of DLD1 cells at least in such a 
scratch assay.  
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Figure 5.7.2: Scratch/wound healing assays of MDCK and DLD1 wild type and Pals1 
knockout cell lines 
Cells were grown in inserts to the confluence. Afterwards, the inserts were removed, leaving a 
gap. Pictures, illustrating the healing, were taken at 0 h (immediately after scratch) and 10 h for 
MDCK or 16 h for DLD1. One representative assay of n=3 independent experiments is shown. 
The scale bars = 200 μm. 
 
5.8 Deregulation of Pals1 expression leads to cellular 
transformation and augmented tumorigenicity 
 One of the main hallmarks of malignant cells is their ability to grow in an 
anchorage-independent manner. The capacity of cells to grow in soft agar 
characterizes the cell transformation and tumorigenicity. Thus, to reveal the 
possible role of Pals1 in cellular tumor conversion, soft agar colony formation 
assays were performed for all previously described mutant cell lines. All 
investigated cells were adjusted to the same number, seeded in soft agar, 
covered with feeder medium and grown for 4 weeks. Afterwards, the colonies 
were stained and counted in ImageJ software.  MDCK wt cells and the derived 
MDCK dogPals1 sh1, sh2 and KO cell lines are normal, thus they underwent 
anoikis and did not form any colonies in soft agar. There were also no 
differences observed comparing HCT 116 Scrbld with HCT116 hPals1 sh1 and 
HCT116 hPals1 sh2 cell lines. However, observing the anchorage-independent 
growth of HCT116 ΔhPals1 in contrast to HCT116 wt, and DLD1 ΔhPals1 
compared to DLD1 wt, it was found that lack of Pals1 promotes further cellular 
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B 
A 
transformation, as both Pals1-KO cell lines formed more colonies compared to 
the controls (Figure 5.8.1 A and B). Rescue of the knockout mutant HCT116 
ΔhPals1 caused a significant decline in colony number. 
  
 
Figure 5.8.1: Soft agar colony formation assay of HCT116 wt, HCT116 ΔhPals1 and 
rescue mutant (A) together with DLD1 wt and DLD1 ΔhPals1 (B) cell lines.  
Colony formation assay was performed in soft agar with 5000 cells per well. Colonies were 
stained with crystal violet 28 days after seeding. One representative assay is shown (left panel) 
and quantification (right panel) is given as means + SEM of n=4 (A) or n=3 (B) independent 
experiments. Numbers of colonies were quantified using ImageJ software and percentage of 
cells, capable of forming colonies in relation to a number of cells seeded, was identified. The 
scale bars = 200 μm. Asterisks indicate statistically significant differences between groups 
(ANOVA/ Dunnett post hoc test, *p < 0.5, ***p < 0.001). 
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5.9 Pals1 knockout in HCT116 cell line enhances cell 
motility and metastases formation in mice 
 To expand our knowledge and to confirm the role of Pals1 protein in 
cancer progression, in the next part of this study HCT116 wt, HCT116 Scrbld, 
HCT116 hPals1 sh1, sh2 and HCT116 ΔhPals1 cells were injected into NSG 
immunodeficient mice. For each cell line, 4-6 mice pups aged 3 days were 
injected subcutaneously with 20 000 cells per mouse in 20 μl of cell culture 
medium (Figure 5.9.1).  
 C C 
 
 
 
 
 
 
Figure 5.9.1: Subcutaneous injection of cultured cells (A, B) and xenograft growth (C) 
in mice 
Each cell line was adjusted to 1 Mio cells/ml in cell culture medium w/o additives. Four to six 
aged 3 days mice (A) were taken per each cell line (group) and injected subcutaneously (B) with 
20 000 cells per animal. Tumor growth was observed over the next 5 weeks (C). 
 Xenograft growth was monitored twice a week and tumor size was 
measured. After 5 weeks the mice were sacrificed; lungs, liver and brain were 
taken for further immunohistochemistry analysis.  
 In contrast to previous data obtained in vitro, where both HCT116 hPals1 
knockdown sh1 and sh2 cell lines showed a similar phenotype, the tumors of 
HCT116 hPals1 sh2 grew much slower than those of the first HCT116 hPals1 
knockdown cell line. Nevertheless, no differences in tumor size were observed 
when comparing the HCT116 Scrbld and HCT116 hPals1 sh1 cell lines. One 
should note that HCT116 ΔhPals1 cells formed dramatically larger tumors, 
compared to those developed from HCT116 wt (Figure 5.9.2). 
 
A 
 
B C 
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Figure 5.9.2: Average tumor weight to body weight index in each mice tumor 
xenograft group 
Five weeks after injection all mice were sacrificed. Mice and tumors were weighed and tumor to 
body weight ratio was identified. Asterisks indicate statistically significant differences between 
groups (ANOVA/ Tukey’s post hoc test, *p < 0.5, ***p < 0.001). 
 To validate whether Pals1 protein levels are crucial for tumor 
dissemination and metastasis formation, the liver and lungs of each mouse were 
used for immunohistochemical studies. For precise analysis, formalin fixed 
paraffin embedded tissue was serial sectioned at a thickness of 20 μm, and 
sections 200 μm apart were stained against specific anti-human pan Cytokeratin 
(panCK). Cytokeratins are cytoskeletal structural proteins found in the 
epithelium. This approach allows detection of only the human epithelia, 
separating it from the mouse tissue. The number of metastases found on 1 mm 
of each organ was counted and used to determine the overall number of 
metastases formed for each group investigated. Whereas no differences in 
metastatic formation were observed in HCT116 Scrbld xenografts compared to 
both HCT116 hPals1-KDs, there were significantly more metastases under Pals1 
knockout compared to HCT116 wt xenografts (Figure 5.9.3).  
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Figure 5.9.3: IHC analysis of human panCK in mouse liver (A), lung (B) and further 
quantification (C) 
Representative pan Cytokeratin immunohistochemical staining of HCT116 wt and HCT116 
ΔhPals1 xenografts, representing liver (A) and lung (B) metastatic formations. Scale bars = 
50μm. Average numbers of metastases per mice, found in liver and lung on 1 mm were 
counted (C). Statistically significant differences between HCT116 wt and HCT ΔhPals1 derived 
metastases respectively are indicated: *p<0.05, Student's t-test. 
 It is also worth noting that there was a vast dissemination of HCT116 
ΔhPals1 cells into the liver, while not a single liver metastasis was found in the 
HCT116 wt group. Altogether, this indicates that the absence of Pals1 plays a 
pivotal role in enhanced cell dissemination and increased metastatic potential.  
5.10 TGF-β pathway is implicated in Pals1-dependend cell 
motility  
 To elucidate the mechanism underlying enhanced cell migration upon 
Pals1 deficiency, it was of interest to look closer on several pathways that are 
known to play a role in cell migration and metastatic process.  In the next part of 
this study, several pathways were inhibited by specific inhibitors and the changes 
in cell migration were observed. Seeing as Pals1 is shown here to regulate the 
Hippo pathway, and recent findings in Drosophila showed this pathway also 
might mediate cell migration (Lucas et al. 2013), Verteporfin was used to inhibit 
YAP activity. Furthermore, SB431542 was applied to cells to block TGF-β 
receptors and to find out the possible influence of the TGF-β pathway in 
enhanced migration upon Pals1-deficiency. Figure 5.10.1 shows the scratch cell 
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migration assay of HCT116 wt and HCT116 ΔhPals1, with and without YAP- and 
TGF-β inhibitors.  
 
Figure 5.10.1: Scratch/wound healing assays of HCT116 wild type and Pals1 knockout 
cell lines under normal conditions or with inhibitors 
Cells were grown in inserts to the confluence. Afterward, the inserts were removed, leaving a 
gap. Pictures, illustrating the healing, were taken at 0 h (immediately after scratch) and 16 h. The 
inhibitors were applied throughout the 16h. Representative assay of n=3 independent 
experiments is shown. The scale bars = 200 μm. 
Comparing HCT116 wt with HCT116 ΔPals1, a lack of Pals1 again lead to 
accelerated cell migration. Interestingly, YAP-inhibition had no impact on the 
enhanced migration of HCT116 ΔhPals1 cells compared to the control HCT116 
wt cell line,  whereas abrogation of TGF-β signaling resulted in slower gap 
closure. This data provides the first hint to the mechanism of Pals1-dependened 
cell motility.  However, to better understand the underlying mechanism, further in 
vitro and in vivo studies need to be performed. 
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VI. Discussion 
Pals1 protein, a core component of Crb polarity complex, has been 
already shown to play a pivotal role in epithelial cell polarization. Prior studies in 
flies showed Stardust (Pals1 ortholog in Drosophila), together with other polarity 
regulators, to be essential for epithelial apicobasal polarization and proper 
subapical region (tight junction analog in flies) formation. Further works on Pals1 
protein in mammals expanded previous findings and affirmed Pals1 to be a key 
player in epithelial cell polarity determination (Straight et al. 2004).  Similar to 
flies, in mammals Pals1 directly interacts with Crb protein through its C-terminal 
domain, while the PDZ-domain governs its ability to bind to Patj and Par6 (Roh 
et al. 2002b; Penkert et al. 2004). Pals1 deficiency results in defects in TJ 
formation and apicobasal polarization (Straight et al. 2004). Remarkably, Pals1 is 
also shown to regulate myelination and radial sorting of axons (Zollinger et al. 
2015). Recent findings revealed Pals1-deficiency to affect Hippo and TGF-β 
pathways and resulted in proteinuria and renal cyst development (Weide et al. 
2017). This study aimed to deepen and expand the understanding of the 
biological functions of Pals1 in epithelial cells. 
It is widely accepted that an excellent method for uncovering gene 
function in cells is to disrupt normal gene expression and explore the resulting 
phenotypes. The RNAi approach has been widely used for such loss-of-function 
studies, however it only reduces the expression of the gene of interest and might 
often result in off-target phenotypes (Sigoillot, King 2011). In contrast, off-target 
activity of CRISPR/Cas9-mediated knockout is fairly low (Gilbert et al. 2014) and 
enables complete gene silencing (Boettcher, McManus 2015). 
So, in this study we combined and applied these two approaches to probe 
Pals1 function in epithelial cells. The data obtained not only confirms and 
extends previous findings of the Pals1 function in maintaining cell polarity, but 
also points to a novel link between cell polarity and tumor progression.  
Pals1 knockdown reduced the expression of Par6γ and E-cadherin in both 
MDCK and HCT116 cells. On the one hand, Par6γ has been shown to be 
inactivated in a large number of epithelial cancers (Marques et al. 2016). On the 
other hand, loss of E-cadherin is one of the fundamental triggers in EMT and cell 
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dissemination in human carcinomas (Yilmaz, Christofori 2009). In addition, the E-
cadherin immunostaining and Ca2+-switch assays of MDCK Pals1-KD cells in this 
thesis are in line with Straight, Shin et al. 2004 and Wang, Chen et al. 2007, who 
show that Pals1 regulates E-cadherin trafficking and tight junction establishment. 
Taken together, simultaneous Par6γ and E-cadherin deregulation might be the 
first sign of cellular transformation under Pals1 knockdown.  
Interestingly, a reduction in Pals1 causes a rise in Par6α expression and 
has no obvious impact on Par6β in MDCK cells. This suggests a further possible 
pathway for enhanced tumorigenicity in Pals1 deficient cells, as Par6α 
overexpression is shown to be responsible for hyperproliferation and enhanced 
invasiveness (Marques et al. 2016).  
Elevated levels of Cdc42 were also observed under Pals1 knockdown in 
MDCK cells. Together with other Rho GTPases RhoA and Rac1, Cdc42 is 
known to regulate a variety of cellular processes, including microfilament and 
actin cytoskeleton network organization. Abnormal Cdc42 expression has been 
previously shown to promote testicular (Kamai et al. 2004) and breast cancer 
(Bray et al. 2013) progression. In contrast to normal tissue, an 
immunohistochemical study of squamous carcinoma in patients pointed again to 
an increased Cdc42 levels. Moreover, Cdc42 might be used as a new tumor 
marker, as it has been shown to contribute to colorectal cancer progression 
(Gomez Del Pulgar et al. 2008). Overexpression studies of Cdc42 in SW480 
colon cancer cell line revealed a significant increase in cell motility in 
scratch/wound healing and Matrigel invasion assays (Gao et al. 2013). 
Another important finding in this study is that both knockdown and 
knockout of Pals1 in all cell lines investigated, caused an extreme rise in alpha 
smooth muscle actin expression. This might suggest that Pals1 is an important 
regulator of EMT, as αSMA is known to be highly upregulated during epithelial to 
mesenchymal transition. EMT itself is characterized by weakening of cell-cell 
contacts, dissolutions of epithelial junctions, loss of apicobasal polarity, 
enhanced motility and invasive behavior (Derynck et al. 2014). Additionally, RT-
PCR analysis of HCT116 ΔhPals1 and MDCK Pals-KD displayed Snail, ZEB1 
and Twist upregulation compared to the control cell lines. These three proteins 
are well-known transcription factors activating EMT mechanisms during 
development and cancer progression. Snail is already shown to directly repress 
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E-cadherin and Crb3a (Harder et al. 2012), whereas ZEB1 interacts with YAP 
(Lehmann et al. 2016). On the other hand, MDCK and HCT116 Pals1-KD cells 
represent the downregulation and mislocalization of E-cadherin. Interestingly, E-
cadherin destabilization is also one of the first hallmarks of EMT. Enhanced 
levels of αSMA and EMT transcription factors, together with reduced adherens 
junctions stability might specify epithelial to mesenchymal transition and 
enhanced tumorigenicity when Pals1 expression is reduced. This hypothesis is 
supported by the considerable increase in motility of MDCK Pals1-KD, MDCK 
ΔdogPals1 and HCT116 ΔhPals1 cells compared to the control, examined in this 
study by scratch/wound healing and transwell migration assays. The Cdc42 
overexpression in MDCK cells lacking Pals1 described above might also 
contribute to augmented cell motility.  
Intriguingly, there were no differences in cell motility identified between 
HCT116 Scrbld and both HCT116 hPals1-KD, as well as between DLD1 wt and 
DLD1 ΔhPals1.  
It is important to understand why fairly efficient Pals1 decline in similar 
colon cancer cell lines results in differing migration capacities. In the first line, 
this may be due to different origin and tumor stage of these cells. According to 
the Dukes classification of colon cancer staging, the DLD1 cell line is classified 
as C stage, describing cancer spread to at least one lymph node. In turn, 
HCT116 represents a later stage D and is characterized by extensive 
metastases and advanced cancer progression (Ahmed et al. 2013b).   
Secondly, regarding DLD1 cells, not only Pals1 knockout cells but also 
wildtype DLD1 cell line showed poor migration in the scratch assay. So, to 
confirm the data obtained it might be necessary to perform further experiments 
such as transwell or Matrigel migration assays. Nevertheless, in the literature 
one can find studies on DLD1 cell motility in scratch/wound healing assays 
during 24 h or even 48 h. Thus, another option is to extend the assay duration 
and add further time points of investigation. However, in this way cell migration 
might be confounded by cell proliferation, as DLD1 have a doubling time of 
approximately 20-24 h (Ahmed et al. 2013a), making it necessary to use 
blockers of proliferation. 
Considering the HCT116 cell line, the cells migrate faster under total 
Pals1 absence compared to HCT116 wt, whereas a reduction in protein level 
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seems not to have an impact on cell motility. In contrast, Pals1 knockdown, as 
well as Pals1 knockout in MDCK cells both support increased cell migration. One 
of the reasons for this might be the different tissue and species origin of the cells. 
MDCK is a cell line isolated from the dog kidney while HCT116 is a human colon 
cancer cell line. The intial Pals1 level is of course also an important determinant. 
Referring to the Figure 5.5.5, it is clear that among all wildtype cell lines 
investigated, MDCK represents the highest Pals1 level and HCT116 the lowest. 
The greater difference between all explored cells is that MDCK a model for 
normal epithelial tissue, whereas HCT116 and DLD1 are originally isolated from 
high-grade primary tumors and are cancer cell lines. The biggest advantage here 
is limitless growth potential, however, one should remember that cancer cell lines 
are often genetically unstable and bear unknown mutations.  
With regards to another finding, that Pals1 expression is downregulated in 
most colon cancer patient samples, especially in high graded tumors (according 
to data obtained by Ludwig Lagleder), it could be assumed that HCT116 already 
has reduced Pals1 levels from the very beginning and a further reduction has no 
further influence on cell motility, while complete Pals1 lack accelerates this cells 
even more. With this in mind, Pals1 might be an important regulator and might 
act as a tumor suppressor in advanced cancer stages.   
In addition, DLD1 cells are characterized by a constitutively active Wnt-
signalling pathway due to a mutation in the adenomatous polyposis coli gene 
(APC) (Boon et al. 2004). APC is a key tumor suppressor, found to be mutated in 
most colon cancers (Kinzler, Vogelstein 1996). Intriguingly, the HCT116 cell line 
has a wild type APC (Yang et al. 2006). Furthermore, karyotyping of diploid 
HCT116 and triploid DLD1 cell lines showed abnormal divergence between them 
(Knutsen et al. 2010). Hence, these might be the other explanations for the 
differences observed in these cell lines upon Pals1 knockout.  
According to our data obtained in this study, Pals1 is not only crucial for 
cell motility but also plays a significant role in Hippo pathway regulation and cell 
proliferation. Although Western Blots show a decrease in the pYAP/YAP ratio in 
MDCK Pals1-KDs and HCT116 hPals1-KDs but not in MDCK, DLD1 and 
HCT116 ΔPals1, we observed an increase in the expression of YAP target 
genes in all Pals1-modified cell lines investigated. Moreover, YAP nuclear 
localization in MDCK Pals1-KD cells compared to MDCK wt supports Pals1 role 
VI. Discussion 
101 
 
in Hippo signaling. Surprisingly, Pals1 knockout in HCT116 cells causes a less 
noticeable impact on the Hippo target genes CTGF, Cyr61 and Birc2 compared 
to those in the MDCK and HCT116 Pals1 knockdown cell lines. With the 
development of the new gene editing tool CRISPR/Cas9, it became much easier 
to modify the genome in an accurate and relative fast manner. However, it has 
already been shown that knockdown and knockout might have distinct effects. 
Knockout of the gene of interest might attenuate consequences or even 
completely compensate deficits, observed under protein knockdown (Khatodia et 
al. 2016). Hence, considering the Hippo pathway, it might be that Pals1 knockout 
triggers some compensatory mechanisms which slightly reduce the impact of 
Pals1 loss, compared to Pals1 decline.  
The Hippo pathway itself is known to regulate organ size and cell 
proliferation. First, in this study, we show that Pals1 knockout drastically 
accelerates cell proliferation in MDCK and DLD1 cells. Contrary to our 
expectations in the MTT cell proliferation assay, neither HCT116 ΔhPals1 nor 
HCT116 ΔhPals1+hPals1 cell lines displayed any changes in cell growth 
compared to HCT116 wt. Nevertheless, in vitro data underlines Hippo pathway 
deregulation in HCT116 ΔhPals1 cells, and thus enhanced cell proliferation 
similar to MDCK and DLD1 Pals1 knockout cells might be evident. However, it 
should be recalled, HCT116 cells derived from high-grade cancer and probably 
because of their phenotype are characterized by weakened TJ. This is then 
probably the cause of the impaired contact inhibition and already in wildtype 
HCT116 deregulated Hippo signaling.  
Nevertheless, investigating the impact of Pals1 knockout on cell 
transformation and colony growth in soft agar assay, it was found out DLD1 and 
HCT116 cells lacking Pals1 had an enhanced proliferation ability in a semisolid 
culture media in contrast to their controls. Pals1 rescue by stable overexpression 
of Pals1 in HCT116 ΔhPals1 also reduced the number of colonies.  Thus, Pals1 
has an effect not only on cell proliferation and cell migration, but a more dramatic 
influence on cell transformation as assessed by growth in soft agar. 
It is widely known that loss of cell-cell contacts and deregulation in cell 
polarity within the epithelium is commonly related to advanced cancer 
progression (Khursheed, Bashyam 2014; Lee, Vasioukhin 2008; Martin-
Belmonte, Perez-Moreno 2012). However, it is still not known exactly how 
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disruption of cell polarity leads to tumorigenesis. In fact, Drosophila studies on 
the Scribble polarity complex revealed neoplastic tumor formation in Lgl, Scribble 
or Dlg mutants. Nevertheless, enhanced tissue overgrowth and increased 
invasiveness in these mutants were observed only when combined with 
disruption of Notch or Ras signaling (Wodarz, Nathke 2007). In line with this, 
reduced Scribble complex members correlate with invasiveness in human 
cancers. Furthermore, a number of studies describe frequent alterations in both 
human aPKC isoforms, together with tumor suppressor Par3 and pro-oncogenic 
Par6 proteins. Crb3 and Patj, direct Pals1 interaction partners, have both already 
been shown to act as tumor suppressors (Lo et al. 2012; Whiteman et al. 2014). 
Although most of the polarity proteins have been shown to be involved in 
oncogenic transformations (Lin et al. 2015), there is still little known about Pals1. 
This study for the first time highlights Pals1 as a possible tumor suppressor.  
To strengthen our supposition that Pals1, apart from its role in maintaining 
cell polarity, has a tumor suppressor function, we used the mouse xenograft 
model in which HCT116 cells harboring deletion of Pals1 were implanted into 
NSG mice. In agreement with results obtained from the in vitro soft agar colony 
formation assay, HCT116 ΔhPals1 xenografts grew significantly faster, 
compared to tumors derived from HCT116 wt. This finding implicates Pals1 in 
cell proliferation not only in vitro but also in vivo. Additionally, in 
immunohistochemical studies we observed the extensive propagation of injected 
tumor cells into mouse organs. 
It is important to realize that among all the immunodeficient mouse strains 
used for human cell engraftment, the NSG mouse provides the best in vivo study 
model. This Nod-Scid mouse with IL2γ receptor knockout is characterized by T 
and B cell depletion, together with extremely low NK cell function and an 
impaired complement system. Notably, the main advantage of the NSG mouse 
model is that tumor metastases in these mice are highly similar to those 
observed in humans (Puchalapalli et al. 2016). As found by Riihimaki et al., the 
most common sites of colorectal cancer metastasis in humans are the liver 
(around 70 %) and the thorax (around 30 %). Metastatic spread to the nervous 
system is found to be very rare, occurring only in 5 % of cases investigated 
(Riihimaki et al. 2016).  
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Similarly to humans, NSG mice bearing HCT116 Pals1 mutant xenografts 
disseminated into liver and lungs, however, no metastatic formations were found 
in the brains. Interestingly, it was only HCT116 ΔhPals1 cells that managed to 
spread into the liver, whereas no dissemination of HCT116 wt in this organ was 
found. This could be the most compelling evidence of the role of Pals1 as a 
tumor suppressor regulating metastatic progression.  
Pals1 deficiency leads to attenuated Hippo pathway activation, so cells 
lacking Pals1 proliferate faster and thus this protein might play a role in the first 
step of cancer development, namely tumor initiation. While this does not explain 
the markedly accelerated tumor progression and invasiveness of Pals1 impaired 
cell, the role of the Hippo pathway in promoting cell motility is still an open 
question. Until now, there are few studies in Drosophila underlining Hippo 
implication in cell migration (Lin et al. 2014; Ma et al. 2017). Nevertheless, the 
possible role of this pathway in EMT and cell invasiveness in humans should be 
still closely investigated.  
The role of Pals1 in other pathways related to cell invasion should also not 
be excluded. It is metastatic spread rather than the primary tumor that is largely 
responsible for high cancer mortality (Guan 2015). Aberrant expression of E-
cadherin and some tight junction proteins as a consequence of Pals1 
deregulation, might be the first key point in the epithelial to mesenchymal 
transition. Further EMT progression is shown to rely on Receptor Tyrosine 
Kinases, the transforming growth factor β superfamily, Wnt and Notch signaling 
together with NFκB driven mechanisms (Geiger, Peeper 2009). Pals1 has 
already shown to mediate NFκB activation in T lymphocytes (Carvalho et al. 
2011b). Because of its implication in YAP-regulation, it seems plausible that 
Pals1 might also be closely linked to Wnt signaling. Interestingly, recent insights 
determined the most common mechanism leading to colon cancer metastasis is 
loss-of-function mutations of the antagonist of the PI3K/Akt pathway – PTEN, 
which in its turn stimulates Akt-regulated cell dissemination (Tariq, Ghias 2016). 
Another thing to remember is that the repression of E-cadherin and the induction 
of Snail and other pro-EMT regulators can be initiated by TGF-β signaling. 
Disruption of TGF-β functionality in the HCT116 ΔhPals1 cell line by TGF-β 
receptor inhibitor resulted in slowing down of migration, indicating a direct 
involvement of this pathway. Thus, it would be of interest to explore in more 
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detail the potential function of Pals1 in relation to the pathways described above, 
in particular TGF-β and PI3K/Akt signaling.  
To summarize, in agreement with recent findings, this study strengthens 
the importance of Pals1 in epithelial cell polarity maintenance and Hippo 
pathway regulation. Moreover, for the first time Pals1 is shown to be crucial for 
EMT and cancer progression. However, the reason for enhanced migration and 
invasiveness in Pals1-deficient cells remains unclear and needs to be 
investigated further. 
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VII. Conclusion and Outlook 
 Epithelial cell polarity is of crucial importance for many tissues. Disruption 
of epithelial cell polarity leads to disassembly of cell-cell and cell-matrix contacts, 
tissue disorganization and finally results in epithelial-to-mesenchymal transition, 
which is implicated in carcinogenesis and metastasis.  
 The present study was designed to investigate the role of Pals1 in 
epithelial cell polarization and explore the molecular link between cell polarity 
and cancer progression. To assess the function of the protein, knockdown and 
knockout studies of the Pals1 function were performed. According to the data 
obtained in vitro, Pals1 deficiency causes abnormal cell morphology and Hippo 
pathway deregulation. Furthermore, lack of Pals1 leads to reduction of E-
cadherin and increased EMT-markers, resulting in enhanced cell motility and 
metastatic formation in vivo. These data, for the first time, point towards Pals1 
being a regulator of a wide range of cellular processes aside from cell polarity 
and suggest the existence of a novel Pals1-mediated mechanism of tumor 
suppression.  
 In the future, it will be important to gain a more accurate and complete 
understanding of the interplay of Pals1 with other mediators of epithelial cell 
polarity. Another crucial point to consider is the mechanism behind the increased 
cell motility occurring with Pals1 deficiency and its convergence with other 
pathways.  
 In conclusion, it is essential to deepen the knowledge of Pals1 function as 
a novel tumor suppressor, with the aim of designing new drugs against the 
deregulation it provokes in a range of pathophysiological conditions.
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